welldevelop
anim
model
necessari
understand
diseas
progress
pathogenesi
immunolog
respons
human
furthermor
test
vaccin
medic
countermeasur
welldevelop
anim
model
essenti
preclin
studi
ideal
anim
model
human
viral
infect
mimic
hostpathogen
interact
diseas
progress
seen
natur
diseas
good
anim
model
viral
infect
allow
mani
paramet
infect
assay
includ
clinic
sign
growth
viru
clinicopatholog
paramet
cellular
humor
immun
respons
virushost
interact
furthermor
viral
replic
accompani
measur
clinic
manifest
patholog
resembl
human
case
better
understand
diseas
process
human
attain
often
one
anim
model
close
repres
human
diseas
given
pathogen
small
anim
model
typic
use
firstlin
screen
initi
test
efficaci
vaccin
therapeut
contrast
nonhuman
primat
nhp
model
often
use
pivot
preclin
studi
approach
also
use
basic
pathogenesi
studi
experi
perform
small
anim
model
possibl
nhp
use
fill
remain
gap
knowledg
advantag
use
mice
develop
anim
model
low
cost
low
genet
variabl
inbr
strain
abund
molecular
biolog
immunolog
reagent
specif
pathogenfre
spf
transgen
knockout
mice
also
avail
major
pitfal
mous
model
pathogenesi
protect
afford
vaccin
therapeut
alway
extrapol
addit
blood
volum
sampl
limit
small
anim
virus
often
need
adapt
serial
passag
speci
induc
product
infect
ferret
airway
anatom
histolog
similar
human
size
enabl
larger
frequent
blood
sampl
collect
make
ideal
model
certain
respiratori
pathogen
ferret
outbr
standard
breed
strain
thu
greater
number
requir
studi
achiev
statist
signific
overcom
result
variabl
respons
addit
spf
transgen
anim
avail
molecular
biolog
reagent
lack
caveat
make
ferret
model
difficult
work
requir
space
mice
rabbitstyl
cage
develop
aggress
behavior
repeat
procedur
nhp
genet
closest
speci
human
thu
diseas
progress
hostpathogen
respons
viral
infect
often
similar
human
howev
ethic
concern
experiment
nhp
along
high
cost
lack
spf
nhp
rais
barrier
studi
nhp
studi
care
design
ensur
least
amount
anim
use
studi
address
critic
question
regard
diseas
pathogenesi
hostpathogen
respons
protect
efficaci
vaccin
therapeut
welldesign
experi
care
evalu
choic
anim
includ
strain
sex
age
furthermor
rout
exposur
dose
close
possibl
rout
exposur
dose
human
diseas
endpoint
studi
also
import
criterion
depend
desir
outcom
model
system
emul
host
respons
human
infect
pathogen
summari
small
anim
model
help
initi
screen
vaccin
therapeut
also
often
benefici
obtain
basic
understand
diseas
nhp
model
use
detail
character
pathogenesi
pivot
preclin
test
studi
ultim
ideal
anim
model
may
avail
case
combin
differ
wellcharacter
anim
model
consid
understand
diseas
progress
test
medic
countermeasur
diseas
chapter
review
anim
model
repres
member
numer
viru
famili
caus
human
diseas
focu
virus
famili
greatest
concern
public
health
worldwid
polioviru
pv
enteroviru
picornaviru
famili
caus
poliomyel
human
natur
host
viru
number
nhp
speci
also
suscept
three
serotyp
pv
caus
paralyt
diseas
rel
rare
infect
individu
ultim
develop
paralysi
human
typic
acquir
transmit
viru
oralfec
rout
although
transmiss
aerosol
droplet
may
also
possibl
viru
replic
oropharyng
intestin
mucosa
made
possibl
resist
pv
stomach
acid
express
peyer
patch
cell
suggest
cell
type
may
import
initi
infect
replic
extraneur
site
vivo
model
viral
diseas
affect
human
preced
invas
central
nervou
system
cnss
occur
two
effect
vaccin
salk
kill
polio
vaccin
deliv
intramuscular
rout
sabin
live
attenu
polio
vaccin
deliv
oral
use
success
elimin
diseas
part
world
world
health
organ
led
long
hardfought
global
polio
erad
campaign
much
success
full
erad
yet
achiev
sinc
case
pv
infect
report
worldwid
year
thu
anim
model
also
need
test
new
vaccin
approach
could
use
toward
erad
polio
area
still
persist
addit
recent
focu
work
pv
anim
model
fraught
urgenc
gain
understand
pv
pathogenesi
erad
effort
complet
work
viru
ceas
anim
model
studi
pv
consist
nhp
model
mous
model
mice
suscept
certain
adapt
pv
strain
variant
mice
infect
intracerebr
develop
diseas
clinic
histopatholog
featur
resembl
human
wildtyp
mice
suscept
wildtyp
pv
howev
discoveri
pv
receptor
led
use
transgen
mice
model
pv
infect
mice
suscept
pv
oral
rout
must
expos
intranas
intramuscular
infect
induc
paralyt
diseas
interestingli
mice
disrupt
interferon
ifn
ab
receptor
gene
suscept
oral
infect
find
given
rise
specul
intact
ifnab
respons
may
respons
limit
infect
major
individu
expos
pv
thu
mous
model
proven
use
gain
better
understand
pv
diseas
pathogenesi
rhesu
macaqu
suscept
pv
oral
rout
use
extens
studi
vaccin
formul
safeti
immunogen
monitor
neurovirul
live
attenu
sabin
vaccin
past
type
pv
strain
bonnet
monkey
also
suscept
oral
inocul
pv
result
gastrointestin
shed
viru
sever
week
paralysi
occur
small
proport
anim
consist
paralyt
diseas
induc
bonnet
monkey
macaca
radiata
exposur
pv
infect
right
ulnar
nerv
elbow
result
limb
paralysi
resembl
human
paralyt
poliomyel
clinic
patholog
bonnet
monkey
use
studi
pv
distribut
patholog
induct
paralyt
poliomyel
provoc
paralysi
hepat
viru
caus
jaundic
public
health
problem
worldwid
incub
period
last
day
averag
day
transmiss
human
occur
oralfec
rout
persontoperson
contact
ingest
contamin
food
water
hepat
viru
caus
acut
selflimit
infect
liver
spectrum
sign
symptom
rang
subclin
diseas
jaundic
fulmin
hepat
case
death
diseas
divid
four
clinic
phase
incub
period
patient
asymptomat
viru
replic
possibl
transmit
other
prodrom
period
might
last
day
week
patient
gener
experienc
anorexia
fever
f
fatigu
malais
myalgia
nausea
vomit
icter
phase
increas
bilirubin
caus
characterist
dark
brownish
color
urin
sign
follow
pale
stool
yellowish
discolor
mucou
membran
conjunctiva
sclera
skin
patient
develop
enlarg
liver
approxim
patient
splenomegali
convalesc
period
resolut
diseas
recoveri
patient
rare
icter
phase
extens
necrosi
liver
occur
patient
show
sudden
increas
bodi
temperatur
mark
abdomin
pain
vomit
jaundic
develop
hepat
encephalopathi
associ
coma
seizur
sign
fulmin
hepat
death
occur
patient
fulmin
hepat
experi
show
hepat
caus
diseas
human
chimpanze
sever
speci
south
american
marmoset
stumptail
monkey
owl
monkey
via
oral
intraven
iv
rout
known
cynomolgu
macaqu
infect
hepat
viru
wild
amado
et
al
use
cynomolgu
macaqu
macaca
fasciculari
experiment
hepat
infect
anim
exhibit
clinic
sign
diseas
viral
shed
observ
saliva
stool
earli
h
postinocul
pi
day
pi
respect
although
mildtomoder
hepat
patholog
observ
macaqu
seroconvers
mildli
increas
alanin
aminotransferas
alt
enzym
associ
liver
function
observ
studi
small
group
anim
four
macaqu
data
consid
conclus
studi
need
better
defin
cynomolgu
macaqu
model
although
hepat
viru
transmit
oralfec
rout
studi
chimpanze
tamarin
show
iv
rout
much
infecti
oral
rout
correl
dose
develop
clinic
diseas
either
speci
experiment
rout
similar
cynomolgu
macaqu
none
speci
show
clinic
sign
diseas
inocul
common
marmoset
callithrix
jacchu
hepat
viru
produc
clinic
sign
diseas
seen
nhp
model
liver
enzym
level
increas
day
pi
monkey
measur
antihepat
antibodi
day
pi
experiment
studi
cell
cultureadapt
hepat
aviru
guinea
pig
challeng
oral
intraperiton
rout
result
clinic
diseas
increas
liver
enzym
seroconvers
viral
load
detect
stool
serum
day
day
respect
liver
patholog
show
mild
hepat
furthermor
histopatholog
indic
viru
replic
extrahepat
tissu
spleen
region
lymph
node
intestin
tract
summari
none
anim
model
hepat
infect
suitabl
studi
pathogenesi
viru
clinic
laboratori
paramet
remain
within
normal
rang
slightli
increas
infect
one
possibl
test
safeti
vaccin
hepat
viru
model
demonstr
viral
shed
norovirus
norwalk
prototyp
member
respons
report
foodborn
gastroenter
case
develop
countri
viru
respons
approxim
death
annual
typic
diseas
cours
selflimit
incid
necrot
enterocol
seizur
infant
symptom
infect
includ
diarrhea
vomit
nausea
abdomin
cramp
dehydr
fever
incub
normal
day
symptom
endur
day
viral
shed
indic
immunocompromis
statu
within
individu
elderli
young
prolong
state
shed
transmiss
occur
predomin
oralfec
rout
contamin
food
water
major
vector
major
hindranc
basic
research
pathogen
lack
cell
cultur
system
therefor
anim
model
use
determin
efficaci
novel
drug
vaccin
also
understand
pathogenesi
viru
therapeut
intervent
consist
rehydr
therapi
antiemet
medic
vaccin
avail
develop
one
expect
challeng
given
immun
short
live
infect
nhp
includ
marmoset
cottontop
tamarin
rhesu
macaqu
infect
norwalk
viru
monitor
extent
viral
shed
howev
clinic
diseas
observ
model
diseas
progress
sever
measur
exclus
assay
viral
shed
determin
viru
need
creat
infect
challeng
oral
rout
challeng
iv
rout
chimpanze
expos
clinic
isol
norwalk
viru
iv
rout
although
none
anim
develop
diseas
symptom
viral
shed
within
fece
observ
within
day
postinfect
last
anywher
day
week
viremia
never
occur
histopatholog
chang
detect
amount
durat
viral
shed
line
observ
upon
human
infect
recent
identifi
caliciviru
rhesu
origin
name
tulan
viru
use
surrog
model
infect
rhesu
macaqu
expos
tulan
viru
intragastr
develop
diarrhea
fever
day
postinfect
viral
shed
achiev
day
immun
system
produc
antibodi
drop
concentr
within
day
postinfect
mirror
shortliv
immun
document
human
intestin
develop
moder
blunt
villi
seen
human
diseas
murin
noroviru
identifi
close
relat
human
norwalk
viru
howev
clinic
virus
present
differ
diseas
murin
noroviru
induc
diarrhea
vomit
develop
persist
infect
contrast
human
diseas
porcin
enter
calicivirus
induc
diarrheal
diseas
young
pig
asymptomat
infect
adult
gnotobiot
pig
success
infect
passag
clinic
norovirus
isol
oral
diarrheal
diseas
develop
anim
abl
shed
viru
stool
major
histopatholog
chang
viral
persist
note
calv
natur
infect
bovin
norovirus
experiment
challeng
calv
oral
inocul
bovin
isol
result
diarrheal
diseas
link
equin
case
human
diseas
confirm
observ
case
fatal
enceph
children
live
area
equin
case
outbreak
eeev
isol
cnss
children
well
pigeon
pheasant
eeev
primarili
affect
area
near
salti
marsh
caus
local
outbreak
diseas
summer
enzoot
cycl
maintain
moist
environ
coastal
area
shade
marshi
salt
swamp
north
america
na
moist
forest
central
america
south
america
sa
bird
primari
reservoir
viru
transmit
via
mosquito
furthermor
forestdwel
rodent
bat
marsupi
frequent
becom
infect
may
provid
addit
reservoir
central
america
sa
despit
known
natur
host
transmiss
cycl
anim
well
character
reptil
amphibian
also
report
becom
infect
eeev
eeev
pathogenesi
diseas
studi
sever
laboratori
anim
natur
host
bird
gener
develop
enceph
except
pheasant
emu
eeev
caus
enceph
mortal
young
chicken
show
sign
extens
myocard
earli
experiment
infect
heart
failur
rather
enceph
caus
death
besid
heart
organ
pancrea
kidney
show
multifoc
necrosi
addit
lymphocytopenia
observ
thymu
spleen
bird
eeev
caus
neuron
damag
newborn
mice
diseas
progress
rapidli
result
death
similarli
eeev
produc
fatal
enceph
older
mice
administ
via
intracerebr
rout
wherea
inocul
via
subcutan
rout
caus
pantrop
infect
eventu
result
enceph
guinea
pig
hamster
also
use
anim
model
eeev
studi
guinea
pig
develop
neurolog
involv
decreas
activ
tremor
circl
behavior
coma
neuron
necrosi
observ
result
brain
lesion
anim
subcutan
inocul
eeev
produc
lethal
biphas
diseas
hamster
sever
lesion
nerv
cell
earli
viscer
phase
viremia
follow
neuroinvas
enceph
death
addit
parenchyma
necros
observ
liver
lymphoid
organ
intraderm
intramuscular
iv
inocul
eeev
nhp
caus
diseas
alway
result
symptom
nervou
system
intracerebr
infect
eeev
result
nervou
system
diseas
fatal
monkey
differ
model
indic
initi
viremia
secondari
nervou
system
infect
overlap
monkey
infect
peripher
rout
intranas
intralingu
inocul
eeev
also
caus
nervou
system
symptom
monkey
less
drastic
caus
intracerebr
inject
aerosol
rout
infect
also
progress
uniformli
lethal
diseas
cynomolgu
macaqu
model
fever
follow
elev
white
blood
cell
liver
enzym
neurolog
sign
subsequ
develop
nhp
becam
moribund
euthan
day
day
postexposur
meningoencephalomyel
main
patholog
observ
brain
anim
similar
clinic
sign
patholog
observ
common
marmoset
infect
eeev
intranas
rout
aerosol
intranas
nhp
model
similar
diseas
progress
patholog
seen
human
diseas
common
marmoset
model
use
comparison
studi
sa
na
strain
eeev
previou
studi
indic
sa
strain
less
virul
na
strain
human
common
marmoset
infect
intranas
either
na
sa
strain
eeev
na
straininfect
anim
show
sign
anorexia
neurolog
involv
euthan
day
challeng
although
sa
straininfect
anim
develop
viremia
remain
healthi
surviv
challeng
epizoot
viral
enceph
hors
previous
describ
argentina
hors
die
western
equin
enceph
viru
weev
central
plain
unit
state
weev
first
isol
brain
hors
outbreak
san
joaquin
valley
california
although
suspect
first
diagnosi
weev
caus
human
enceph
occur
viru
recov
brain
child
fatal
enceph
hors
sign
diseas
fever
loss
coordin
drowsi
anorexia
lead
prostrat
coma
death
affect
anim
weev
also
infect
speci
bird
often
caus
fatal
diseas
sparrow
weev
infect
occur
throughout
western
na
sporad
sa
circul
mosquito
vector
wild
bird
chicken
domest
bird
pheasant
rodent
rabbit
ungul
tortois
snake
natur
reservoir
weev
weev
caus
epidem
enceph
human
hors
emu
fatal
rate
lower
eeev
predomin
young
children
older
year
demonstr
clinic
symptom
diseas
sever
diseas
seizur
fatal
enceph
signific
sequela
like
occur
infant
young
children
typic
diseas
progress
asymptomat
seropreval
human
fairli
common
endem
area
speci
use
develop
anim
model
weev
mice
hamster
guinea
pig
poni
studi
poni
result
viremia
anim
day
pi
fever
observ
anim
six
exhibit
sign
enceph
subcutan
inocul
weev
suckl
mice
start
show
sign
diseas
h
die
within
h
suckl
mice
heart
organ
patholog
chang
observ
convers
adult
mice
exhibit
sign
lethargi
ruffl
fur
day
postinfect
mice
sever
ill
day
appear
hunch
dehydr
death
occur
day
brain
mesoderm
tissu
heart
lung
liver
kidney
involv
intracerebr
intranas
rout
infect
result
fatal
diseas
highli
depend
dose
intraderm
subcutan
inocul
caus
fatal
mice
regardless
amount
viru
studi
demonstr
although
length
incub
period
diseas
durat
vari
weev
infect
result
mortal
hamster
rout
inocul
progress
lack
coordin
shiver
rapid
noisi
breath
corneal
opac
conjunctiv
discharg
result
close
eyelid
indic
diseas
case
cn
involv
evid
intracerebr
intraperiton
intraderm
inocul
weev
highli
infecti
guinea
pig
intraperiton
inocul
weev
fatal
guinea
pig
regardless
viru
inoculum
anim
exhibit
sign
ill
day
follow
death
day
nalca
unpublish
result
limit
studi
perform
nhp
intranas
rout
infect
caus
sever
lethal
enceph
rhesu
macaqu
reed
et
al
expos
cynomolgu
macaqu
low
high
dose
aerosol
weev
anim
subsequ
develop
fever
increas
white
blood
count
cn
involv
demonstr
cynomolgu
macaqu
model
would
use
test
vaccin
therapeut
weev
venezuelan
equin
enceph
viru
veev
maintain
natur
cycl
small
rodent
mosquito
spread
epizoot
strain
viru
equin
lead
high
viremia
follow
lethal
enceph
tangenti
spread
human
veev
easili
spread
aerosol
rout
make
consider
danger
laboratori
exposur
human
veev
infect
caus
sudden
onset
malais
fever
chill
headach
sore
throat
symptom
persist
day
follow
period
gener
weak
enceph
occur
small
percentag
adult
howev
rate
children
may
high
neurolog
symptom
rang
nuchal
rigid
ataxia
convuls
sever
case
exhibit
coma
paralysi
overal
mortal
rate
human
laboratori
anim
mice
guinea
pig
nhp
exhibit
differ
patholog
respons
infect
veev
lymphat
system
gener
target
anim
infect
cn
involv
variabl
differ
anim
speci
diseas
caus
veev
progress
rapidli
without
show
sign
cn
diseas
guinea
pig
hamster
mortal
typic
observ
within
day
infect
fatal
dose
depend
veev
infect
last
longer
mice
develop
sign
nervou
system
diseas
day
death
day
later
lethal
dose
mice
chang
depend
age
mice
rout
exposur
contrast
guinea
pig
hamster
time
death
mice
dose
depend
mortal
observ
gener
within
day
infect
fatal
dose
depend
subcutaneousderm
infect
mous
model
result
encephalit
diseas
similar
seen
hors
human
viru
begin
replic
drain
lymph
node
h
pi
eventu
viru
enter
brain
primarili
via
olfactori
system
furthermor
aerosol
exposur
mice
veev
result
massiv
infect
olfactori
neuroepithelium
olfactori
nerv
olfactori
bulb
viral
spread
brain
result
necrot
panenceph
aerosol
dermal
inocul
rout
caus
neurolog
patholog
mice
much
faster
rout
exposur
clinic
sign
diseas
mice
infect
aerosol
ruffl
fur
lethargi
hunch
progress
death
intranas
challeng
mice
high
dose
veev
caus
high
morbid
mortal
viral
titer
brain
peak
day
postchalleng
stay
high
anim
die
day
postchalleng
protein
cytokin
array
done
brain
infect
mice
show
elev
interleukin
il
monocyt
chemoattract
ifng
regul
normal
tcell
express
secret
level
model
use
success
test
antivir
veev
xi
viral
diseas
veev
infect
caus
typic
biphas
febril
respons
nhp
initi
fever
observ
h
infect
last
h
secondari
fever
gener
began
day
last
day
veevinfect
nhp
exhibit
mild
symptom
anorexia
irrit
diarrhea
tremor
leucopenia
common
anim
exhibit
fever
support
leucopenia
observ
microscop
chang
lymphat
tissu
earli
destruct
lymphocyt
lymph
node
spleen
mild
lymphocyt
infiltr
hepat
triad
focal
myocardi
necrosi
lymphocyt
infiltr
observ
monkey
infect
veev
surprisingli
characterist
lesion
cn
observ
histopatholog
monkey
spite
lack
clinic
sign
infect
primari
lesion
lymphocyt
perivascular
cuf
glial
prolifer
gener
observ
day
postinfect
secondari
febril
episod
cynomolgu
macaqu
develop
similar
clinic
sign
includ
fever
viremia
lymphopenia
enceph
upon
aerosol
exposur
veev
chikungunya
viru
member
genu
alphavirus
specif
semliki
forest
complex
respons
multitud
epidem
mainli
within
africa
southeast
asia
viru
transmit
aed
mosquito
given
widespread
endem
aed
mosquito
chikungunya
viru
potenti
spread
previous
unaffect
area
typifi
emerg
diseas
first
time
island
southwest
indian
ocean
includ
french
la
reunion
island
appear
central
itali
incub
period
mosquito
bite
day
follow
selflimit
acut
phase
last
day
symptom
period
includ
fever
arthralgia
myalgia
rash
headach
weak
nausea
vomit
polyarthralgia
report
individu
typic
develop
stoop
postur
due
pain
approxim
infect
individu
joint
pain
last
month
resolut
primari
diseas
possibl
relaps
underli
health
condit
includ
diabet
alcohol
renal
diseas
increas
risk
develop
sever
form
diseas
includ
hepat
encephalopathi
children
age
year
increas
risk
develop
neurolog
manifest
effect
vaccin
antivir
wildtyp
adult
mice
permiss
chikungunya
viru
infect
intraderm
inocul
howev
demonstr
neonat
mice
suscept
sever
depend
upon
age
infect
sixdayold
mice
develop
paralysi
day
die
day
wherea
ninedayold
mice
abl
recov
infect
day
mice
longer
permiss
diseas
infect
mice
develop
loss
balanc
hind
limb
drag
skin
lesion
neonat
mice
also
use
model
neurolog
complic
adult
mous
model
develop
inject
ventral
side
footpad
mice
viremia
last
day
accompani
foot
swell
note
inflamm
musculoskelet
tissu
adult
ifnabr
knockout
mice
also
develop
mild
diseas
symptom
includ
muscl
weak
lethargi
symptom
mirror
human
infect
adult
mice
die
within
day
model
use
identifi
viral
cellular
tropism
fibroblast
imprint
control
region
icr
mice
also
use
diseas
model
neonat
mice
subcutan
inocul
passag
clinic
isol
chikungunya
viru
develop
lethargi
loss
balanc
difficulti
walk
mortal
low
newborn
icr
mice
respect
remain
mice
fulli
recov
within
week
infect
drawback
ifna
br
mice
diseas
result
immunopathogenesi
occur
human
case
given
mice
immunocompromis
longtail
macaqu
challeng
clinic
isol
viru
develop
similar
clinic
diseas
human
initi
monkey
develop
high
viremia
fever
rash
period
viremia
resolv
viru
could
detect
lymphoid
liver
mening
joint
muscl
tissu
last
stage
mimick
chronic
phase
viru
could
detect
two
month
infect
although
arthralgia
note
dengu
viru
transmit
via
mosquito
vector
aed
aegypti
aed
albopictu
given
endem
vector
estim
half
world
popul
risk
exposur
dengu
viru
result
approxim
million
case
dengu
year
burden
diseas
tropic
subtrop
region
latin
america
south
asia
southeast
asia
estim
death
year
caus
dengu
hemorrhag
fever
dhf
four
serotyp
dengu
viru
number
capabl
caus
wide
spectrum
diseas
rang
asymptomat
sever
develop
dhf
incub
rang
day
averag
day
viru
target
dendrit
cell
macrophag
mosquito
bite
typic
infect
result
classic
dengu
fever
df
selflimit
flulik
symptom
conjunct
retroorbit
pain
headach
skin
rash
bone
muscl
pain
dhf
follow
vascular
leak
syndrom
low
platelet
count
result
hemorrhag
extrem
case
dengu
shock
syndrom
dss
develop
character
hypotens
shock
circulatori
failur
thrombocytopenia
hallmark
clinic
sign
infect
aid
differenti
diagnosi
sever
diseas
higher
propens
occur
upon
secondari
infect
differ
dengu
viru
serotyp
hypothes
occur
due
antibodydepend
enhanc
ade
approv
vaccin
drug
hospit
patient
receiv
support
care
includ
fluid
replac
develop
anim
model
import
note
mosquito
typic
deposit
pfu
therefor
optim
rang
use
challeng
comprehens
review
literatur
regard
anim
model
dengu
infect
recent
publish
zompi
et
al
sever
laboratori
mous
strain
includ
aj
balbc
permiss
dengu
infect
howev
result
diseas
littl
resembl
human
clinic
sign
death
result
paralysi
higher
dose
adapt
dengu
viru
strain
induc
dhf
symptom
balbc
model
also
yield
asymptomat
infect
mouseadapt
strain
dengu
viru
introduc
mice
develop
vascular
leak
syndrom
similar
sever
diseas
seen
human
passiv
transfer
monoclon
dengu
antibodi
within
mice
lead
ade
cours
infect
viremia
increas
anim
die
due
vascular
leak
syndrom
anoth
strain
inject
balbc
caus
liver
damag
hemorrhag
manifest
vascular
permeabl
intracrani
inject
suckl
mice
dengu
viru
lead
death
use
test
efficaci
therapeut
scid
mice
engraft
human
tumor
cell
develop
paralysi
upon
infect
thu
use
pathogenesi
studi
df
symptom
develop
infect
mice
engraft
human
progenitor
cell
raghu
mice
develop
fever
symptom
upon
infect
passag
clinic
isol
laboratoryadapt
strain
dengu
viru
passag
clinic
isol
dengu
viru
type
recent
use
creat
model
immunocompet
adult
mice
interperiton
inject
balbc
caus
lethal
day
postinfect
dosedepend
manner
first
indic
infect
weight
loss
begin
day
follow
thrombocytopenia
drop
systol
blood
pressur
along
note
increas
liver
enzym
aspart
aminotransferas
ast
alt
also
observ
viremia
establish
day
model
mimick
characterist
symptom
observ
human
dhfdss
case
novel
model
develop
use
infect
mosquito
rout
transmiss
hunsg
mice
femal
mosquito
intrathorac
inocul
clinic
isol
dengu
viru
type
infect
mosquito
fed
upon
mous
footpad
allow
transmiss
viru
via
natur
rout
amount
viru
detect
within
mous
directli
proport
amount
mosquito
expos
four
five
optim
detect
viral
rna
line
observ
human
infect
sever
thrombocytopenia
develop
day
model
intrigu
given
diseas
enhanc
mosquito
deliveri
viru
comparison
inject
viru
nhp
model
use
subcutan
inocul
attempt
induc
diseas
although
anim
permiss
viral
replic
lower
degre
observ
human
infect
immunosuppress
drug
cyclophosphamid
enhanc
infect
rhesu
macaqu
allow
viru
invad
monocyt
throughout
preliminari
studi
clinic
diseas
detect
circumv
higher
dose
dengu
viru
use
iv
challeng
rhesu
macaqu
hemorrhag
manifest
appear
day
result
petechia
hematoma
coagulopathi
howev
symptom
develop
develop
would
allow
model
use
test
novel
therapeut
vaccin
although
primat
develop
diseas
upon
infect
dengu
immun
system
produc
antibodi
similar
observ
cours
human
infect
advantag
studi
ade
sequenti
infect
led
crossreact
antibodi
respons
demonstr
human
mice
phenotyp
also
seen
upon
passiv
transfer
monoclon
antibodi
dengu
subsequ
infect
viru
rhesu
macaqu
expos
manner
develop
viremia
higher
previous
report
howev
clinic
sign
appar
lack
induc
dhf
dss
symptom
hinder
examin
pathogenesi
within
model
japanes
enceph
viru
jev
lead
caus
childhood
viral
enceph
southern
eastern
asia
problem
among
militari
personnel
travel
region
first
isol
brain
patient
die
enceph
japan
culex
mosquito
breed
rice
field
transmit
viru
bird
mammal
mostli
domest
pig
human
diseas
symptom
rang
mild
febril
ill
acut
meningomyeloenceph
asymptomat
incub
period
week
patient
show
sign
fever
headach
stupor
gener
motor
seizur
especi
children
viru
caus
enceph
invad
destroy
cortic
neuron
fatal
rate
rang
survivor
neurolog
psychiatr
sequela
jev
viru
caus
fatal
infant
mice
rout
inocul
differ
pathogenesi
outcom
seen
viru
given
intraperiton
inocul
differ
depend
amount
viru
specif
viral
strain
use
biphas
viral
multipl
peripher
inocul
observ
mice
tissu
primari
viru
replic
occur
peripher
tissu
secondari
replic
phase
brain
hamster
anoth
small
anim
speci
use
anim
model
jev
fatal
observ
hamster
inocul
intracerebr
intranas
peripher
inocul
caus
asymptomat
viremia
studi
rabbit
guinea
pig
show
rout
inocul
jev
produc
asymptomat
infect
serial
sampl
studi
wistar
rat
inocul
intracerebr
jev
indic
jev
caus
overproduct
free
radic
neuron
apoptosi
neuron
cell
follow
studi
group
show
although
cytokin
tumor
necrosi
factor
tnf
ifng
chemokin
increas
gradual
peak
day
pi
jevin
rat
level
eventu
declin
correl
level
cytokin
chemokin
neuron
damag
intracerebr
inocul
jev
caus
sever
histopatholog
chang
brain
hemispher
rhesu
monkey
symptom
weak
tremor
convuls
began
appear
day
indic
sign
encephalomyel
occur
day
postinfect
anim
follow
death
occur
day
postinfect
anim
follow
death
although
intranas
inocul
jev
result
fatal
rhesu
cynomolgu
monkey
peripher
inocul
caus
asymptomat
viremia
speci
west
nile
viru
west
nile
viru
wnv
first
isol
blood
woman
west
nile
district
uganda
initi
isol
wnv
viru
subsequ
isol
patient
bird
mosquito
egypt
earli
shown
caus
enceph
human
hors
wnv
recogn
widespread
flavivirus
geograph
distribut
includ
africa
middl
east
western
asia
europ
australia
viru
first
reach
western
hemispher
summer
outbreak
involv
human
hors
bird
new
york
citi
metropolitan
area
sinc
rang
area
affect
wnv
quickli
extend
older
peopl
children
suscept
wnv
diseas
wnv
gener
caus
asymptomat
diseas
mild
undifferenti
fever
west
nile
fever
last
day
mortal
rate
neuroinvas
diseas
rang
sever
complic
commonli
seen
elderli
report
case
fatal
rate
hepat
myocard
pancreat
unusu
sever
nonneurolog
manifest
wnv
infect
although
mani
earli
laboratori
studi
wn
enceph
perform
nhp
mice
rat
hamster
hors
pig
dog
cat
model
use
studi
diseas
inocul
wnv
nhp
intracerebr
result
develop
either
enceph
febril
diseas
asymptomat
infect
depend
viru
strain
dose
viral
persist
observ
anim
regardless
outcom
infect
ie
asymptomat
fever
enceph
thu
viral
persist
regard
typic
result
nhp
infect
variou
wnv
strain
intracerebr
subcutan
inocul
viru
local
predominantli
brain
may
also
found
kidney
spleen
lymph
node
wnv
result
clinic
diseas
nhp
although
anim
show
low
level
viremia
wnv
also
extens
studi
small
anim
classic
laboratori
mous
strain
suscept
lethal
infect
intracerebr
intraperiton
rout
result
enceph
mortal
intraderm
rout
pathogenesi
studi
indic
langerhan
dentrit
cell
initi
viral
replic
site
skin
infect
langerhan
cell
migrat
lymph
node
viru
enter
blood
lymphat
thorac
duct
dissemin
peripher
tissu
secondari
viral
replic
viru
eventu
travel
cn
caus
patholog
similar
human
case
tesh
et
al
develop
model
wn
enceph
use
golden
hamster
mesocricetu
auratu
hamster
appear
normal
first
day
becam
letharg
approxim
day
develop
neurolog
symptom
day
mani
sever
affect
anim
die
day
infect
viremia
detect
hamster
within
h
infect
persist
day
although
substanti
chang
intern
organ
progress
patholog
differ
seen
brain
spinal
cord
infect
anim
furthermor
similar
abovement
monkey
experi
pogodina
et
al
persist
wnv
infect
found
brain
hamster
etiolog
agent
sever
acut
respiratori
syndrom
sar
sarscoronaviru
cov
emerg
spread
throughout
countri
period
month
infect
peopl
caus
nearli
death
main
mechan
transmiss
sarscov
droplet
spread
also
viabl
dri
form
surfac
day
detect
stool
suggest
mode
transmiss
also
possibl
although
member
famili
usual
caus
mild
ill
sarscov
infect
case
fatal
major
case
peopl
age
year
incub
period
day
clinic
sign
sar
includ
gener
malais
fever
chill
diarrhea
dyspnea
cough
sar
case
pneumonia
may
develop
progress
acut
respiratori
distress
syndrom
ard
fever
usual
dissip
within
week
coincid
induct
high
level
neutral
antibodi
human
sarscov
replic
destroy
respiratori
epithelium
great
deal
pathogenesi
due
subsequ
immun
respons
infiltr
persist
within
lung
diffus
alveolar
damag
dad
common
sequela
sarscov
infect
viru
isol
secret
upper
airway
earli
later
stage
infect
well
tissu
sarscov
replic
mani
speci
includ
dog
cat
pig
mice
rat
ferret
fox
nhp
chines
palm
civet
raccoon
dog
bat
possibl
natur
host
model
captur
aspect
human
clinic
diseas
pyrexia
respiratori
sign
mortal
viral
replic
patholog
gener
sarscov
diseas
cours
model
speci
much
milder
shorter
durat
human
viral
replic
variou
anim
model
may
occur
without
clinic
ill
andor
histopatholog
chang
bestcharacter
model
use
mice
hamster
ferret
nhp
tabl
mous
model
sarscov
typic
inocul
intranas
rout
light
anesthesia
young
old
balbc
mice
expos
sarscov
viral
replic
detect
lung
nasal
turbin
peak
day
clearanc
day
postexposur
also
viral
replic
within
small
intestin
young
balbc
mice
howev
young
mice
clinic
sign
asid
reduc
weight
gain
littl
inflamm
within
lung
pneumon
intranas
sarscov
infect
also
yield
reduc
weight
gain
viral
replic
lung
peak
day
clearanc
day
contrast
balbc
mice
interstiti
pneumon
alveolar
damag
death
also
occur
old
mice
resembl
agedepend
virul
observ
human
mice
mice
show
outcom
sarscovinfect
similar
observ
balbc
mice
lower
titer
less
prolong
diseas
one
problem
difficult
obtain
larg
number
mice
older
year
number
immunocompromis
knockout
mous
model
intranas
sarscov
infect
also
develop
mice
infect
sarscov
intranas
rout
develop
bronchiol
peribronchiolar
inflammatori
infiltr
interstiti
inflamm
adjac
alveolar
septa
viral
replic
diseas
mice
resolv
day
postexposur
beig
mice
infect
sarscov
similar
outcom
infect
balbc
mice
regard
viral
replic
time
viral
clearanc
lack
clinic
sign
signal
transduc
activ
ko
mice
infect
intranas
sarscov
sever
diseas
weight
loss
pneumon
interstiti
pneumonia
death
ko
mous
model
therefor
use
studi
pathogen
patholog
evalu
vaccin
syrian
golden
hamster
strain
lvg
also
suscept
intranas
exposur
sarscov
administr
tcid
tissu
cultur
infect
dose
along
period
transient
viremia
sarscov
replic
nasal
turbin
lung
result
pneumon
obviou
sign
diseas
exercis
wheel
use
monitor
decreas
nighttim
activ
mortal
observ
dose
depend
could
genet
differ
anim
strain
inbr
damag
observ
liver
spleen
despit
detect
viru
within
tissu
sever
studi
shown
intratrach
inocul
sarscov
anesthet
ferret
mustela
furo
result
lethargi
fever
sneez
nasal
discharg
clinic
diseas
observ
sever
studi
sarscov
detect
pharyng
swab
trachea
tracheobronchi
lymph
node
high
titer
within
lung
mortal
observ
around
day
postexposur
well
mild
alveolar
damag
lung
occasion
accompani
sever
patholog
within
lung
fever
overt
respiratori
sign
lung
damag
mortal
ferret
intratrach
model
sarscov
infect
perhap
similar
human
sar
albeit
shorter
time
cours
sarscov
infect
nhp
intrans
intratrach
rout
gener
result
mild
infect
resolv
quickli
sarscov
infect
old
world
monkey
rhesu
macaqu
cynomolgu
macaqu
cyno
african
green
monkey
agm
studi
variabl
result
possibl
due
outbr
natur
group
studi
previou
exposur
relat
pathogen
clinic
ill
viral
load
consist
howev
replic
within
lung
dad
featur
infect
primat
speci
cyno
ill
other
rash
lethargi
respiratori
sign
patholog
rhesu
littl
diseas
mild
find
upon
histopatholog
analysi
agm
infect
sarscov
overt
clinic
sign
dad
pneumon
document
viral
replic
detect
day
lung
agm
howev
infect
resolv
progress
fatal
ard
farm
chines
mask
palm
civet
sold
open
market
china
thought
involv
sarscovoutbreak
intratrach
intranas
inocul
civet
sarscovresult
lethargi
decreas
aggress
fever
diarrhea
conjunct
leucopenia
pneumon
alveolar
septal
enlarg
lesion
similar
observ
ferret
nhp
also
observ
laboratoryinfect
civet
common
marmoset
also
shown
suscept
sarscov
infect
vaccin
develop
relat
anim
cov
chicken
cattl
dog
cat
swine
use
liveattenu
kill
dna
viralvector
vaccin
strategi
import
issu
highlight
work
vaccin
cov
vaccin
develop
cat
may
induc
sever
diseas
immun
mice
immunopatholog
upon
sarscov
challeng
sever
hepat
vaccin
ferret
antibodi
enhanc
liver
report
addit
rechalleng
agm
show
limit
viral
replic
signific
lung
inflamm
includ
alveol
interstiti
pneumonia
persist
long
period
time
viral
clearanc
mous
nhp
model
increas
virul
may
develop
adapt
viru
repeat
passag
within
speci
interest
sar
human
transgen
mice
avail
mammal
experiment
natur
expos
rabi
viru
found
suscept
highli
neurotrop
viru
member
lyssaviru
genu
transmit
bite
infect
anim
human
viru
abl
replic
within
muscl
cell
site
bite
travel
cn
reach
cn
retrograd
axon
transport
viru
replic
within
neuron
creat
inflamm
necrosi
viru
subsequ
spread
throughout
bodi
via
peripher
nerv
typic
incub
period
day
highli
depend
upon
locat
bite
proxim
brain
major
factor
onset
symptom
prodrom
stage
last
day
viru
initi
invad
cn
flulik
symptom
norm
conjunct
pain
inflamm
site
bite
subsequ
two
form
diseas
develop
case
individu
develop
encephalit
furiou
form
form
mark
hyperexcit
autonom
dysfunct
hydrophobia
paralyt
dumb
form
character
ascend
paralysi
ultim
form
result
death
day
onset
symptom
symptom
develop
proven
effect
therapi
develop
world
death
caus
lack
access
medic
care
includ
postexposur
prophylaxi
na
fatal
case
result
late
diagnosi
syrian
hamster
challeng
rabi
viru
intracerebr
intraperiton
intraderm
intranas
anim
die
result
exposur
although
intracerebr
intranas
inocul
led
furiou
form
depict
extrem
irrit
spasm
excess
saliv
cri
viru
use
isol
infect
dog
brain
passag
swiss
albino
mice
anim
inocul
intracerebr
inject
develop
diseas
within
day
wherea
rout
entri
develop
diseas
within
day
model
use
studi
test
novel
vaccin
candid
mice
extens
studi
anim
model
rabi
shown
swiss
albino
mice
intracerebr
inject
viru
isol
dog
develop
paralyt
form
diseas
day
initi
challeng
balbc
mice
univers
suscept
intracerebr
inject
rabi
viru
within
day
diseas
symptom
includ
paralysi
cachexia
bristl
appear
day
death
natur
rout
infect
via
peripher
inject
masset
muscl
test
icr
mice
mice
develop
neurolog
sign
includ
limb
paralysi
die
within
day
icr
mice
instrument
analyz
novel
vaccin
correl
protect
line
mice
also
use
assess
valu
ketamin
treatment
induc
coma
rabi
infect
anoth
mous
line
use
neurotrophin
receptordefici
mous
mous
develop
fatal
enceph
inocul
intracerebr
challeng
viru
standard
baxdefici
mice
also
use
determin
role
apoptot
cell
death
brain
cours
infect
viral
isol
silverhair
bat
also
use
mous
model
strain
advantag
given
respons
major
death
north
na
earli
death
phenomenon
typifi
decreas
time
death
subset
individu
anim
vaccin
subsequ
expos
rabi
trend
demonstr
experiment
swiss
outbr
mice
primat
cynomolgu
rhesu
infect
passag
rabi
viru
creat
nhp
model
high
titer
viru
need
induc
diseas
exposur
found
univers
fatal
anim
surviv
beyond
week
within
experi
develop
clinic
diseas
succumb
infect
primat
develop
diseas
refus
food
progress
less
activ
death
last
h
day
anim
symptom
die
within
week
bat
experiment
challeng
rabi
vampir
bat
desmodu
rotundu
intramuscularli
inject
bat
viral
isol
display
clinic
sign
includ
paralysi
half
popul
studi
anim
develop
diseas
durat
day
incub
period
rang
day
regardless
diseas
manifest
challeng
anim
die
skunk
challeng
intramuscularli
intranas
either
challeng
viru
strain
skunk
viral
isol
interestingli
challeng
viru
strain
readili
produc
paralyt
form
wherea
street
form
rabi
develop
furiou
form
howev
challeng
strain
viru
result
shorter
incub
period
day
comparison
day
seen
street
viru
filovirida
consist
two
wellestablish
genera
ebola
viru
marburg
viru
marv
newli
discov
group
cuevaviru
tabl
two
ebola
virus
known
forest
tafv
previous
name
cote
circumflex
divoir
ciebov
reston
restv
caus
major
outbreak
lethal
diseas
human
diseas
human
character
aberr
innat
immun
number
clinic
symptom
fever
nausea
vomit
arthralgiamyalgia
headach
sore
throat
diarrhea
abdomin
pain
anorexia
numer
other
approxim
patient
develop
petechia
greater
percentag
depend
specif
strain
may
develop
bleed
variou
site
gum
punctur
site
stool
etc
natur
transmiss
epidem
thought
direct
contact
needl
stick
hospit
set
howev
much
research
interest
filovirus
primarili
stem
biodefens
need
particularli
aerosol
biothreat
intramuscular
intraperiton
aerosol
model
develop
mice
hamster
guinea
pig
nhp
studi
pathogenesi
correl
immun
test
countermeasur
filovirus
high
lethal
rate
human
scientist
look
model
uniformli
lethal
stringent
test
efficaci
candid
vaccin
therapeut
immunocompet
mice
success
infect
wildtyp
filovirus
due
control
infect
murin
type
ifn
respons
howev
wildtyp
inbr
mice
suscept
filoviru
serial
passag
balbc
mice
strain
choic
intraperiton
inocul
maebov
suscept
aerosol
rout
aerosol
infect
immunocompet
mice
panel
bxd
balb
c
dba
recombin
inbr
strain
screen
one
strain
shown
particularli
suscept
airborn
maebov
lethal
low
high
dose
pfu
mice
develop
weight
loss
succumb
infect
day
postexposur
aerosol
infect
model
use
wholebodi
exposur
chamber
expos
mice
age
week
maebov
aerosol
mass
median
aerodynam
diamet
mmad
approxim
mm
geometr
standard
deviat
approxim
min
anoth
approach
use
immunodefici
mous
strain
scid
ko
ifn
receptor
ko
perforin
ko
wildtyp
ebov
inoculum
intraperiton
aerosol
rout
mice
typic
monitor
clinic
diseas
score
base
activ
appear
weight
loss
moribund
condit
surviv
coagulopathi
hallmark
filoviru
infect
human
observ
bleed
subset
anim
failur
blood
sampl
coagul
late
infect
liver
kidney
spleen
lung
tissu
taken
moribund
mice
patholog
characterist
filoviru
diseas
nhp
although
mous
studi
use
maebov
ebov
intraperiton
marv
model
also
avail
mamarv
maebov
model
particularli
use
screen
novel
antivir
compound
hamster
frequent
use
studi
cardiovascular
diseas
coagul
disord
thu
serv
basi
numer
viral
hemorrhag
fever
model
intraperiton
maebov
infect
model
develop
syrian
hamster
model
use
test
vesicular
stomat
viru
vector
vaccin
approach
use
male
syrian
hamster
infect
maebov
viru
present
tissu
blood
collect
day
anim
succumb
diseas
day
detail
account
model
present
intern
scientif
meet
ebihara
feldmann
et
al
report
scientif
journal
time
write
chapter
guinea
pig
model
filoviru
infect
develop
intraperiton
aerosol
rout
use
guinea
pigadapt
ebov
gpebov
marv
gpmarv
guinea
pig
model
filoviru
infect
quit
use
develop
fever
monitor
frequent
hourli
interv
telemetri
addit
anim
larg
enough
regular
blood
sampl
measur
coagul
defect
observ
infect
progress
hartley
guinea
pig
expos
aerosol
gpmarv
gpebov
becom
moribund
time
compar
nhp
gener
succumb
infect
day
postexposur
aerosol
exposur
gpebov
uniformli
lethal
high
low
dose
pfu
target
dose
lethal
drop
low
pfu
present
dose
airborn
gpmarv
protract
diseas
seen
anim
weight
loss
common
find
guinea
pig
expos
gpebov
gpmarv
fever
becom
appar
day
occur
rapidli
gpebov
expos
guinea
pig
gpmarv
exposur
lymphocyt
neutrophil
increas
earlier
part
diseas
platelet
level
steadili
drop
diseas
progress
increas
coagul
time
seen
earli
day
postexposur
blood
chemistri
ie
alt
ast
alkalin
phosphatas
alkp
blood
urea
nitrogen
indic
problem
liver
kidney
function
also
alter
late
diseas
cours
nhp
model
filoviru
infect
prefer
model
advanc
diseas
character
test
countermeasur
close
mimic
diseas
immun
correl
seen
human
old
world
primat
primarili
use
develop
intraperiton
intramuscular
aerosol
model
filoviru
infect
uniformli
lethal
filoviru
model
develop
viru
strain
cynomolgu
macaqu
rhesu
macaqu
lesser
degre
agm
marmoset
lowpassag
human
isol
passag
anim
sought
develop
nhp
model
satisfi
food
drug
administr
fda
anim
rule
promin
featur
infect
onset
fever
day
postexposur
alter
liver
function
enzym
alt
ast
alkp
decreas
platelet
increas
coagul
time
clinic
diseas
paramet
may
slightli
delay
onset
aerosol
model
petichi
rash
common
sign
filoviru
diseas
may
frequent
observ
cynomolgu
macaqu
nhp
speci
dyspnea
late
infect
promin
featur
diseas
aerosol
exposur
number
pronounc
patholog
find
includ
multifoc
necrosi
fibrin
lesion
particularli
within
liver
spleen
lymphocytolysi
lymphoid
deplet
also
observ
multilead
surgic
implant
telemetri
devic
use
continu
collect
temperatur
blood
pressur
heart
rate
activ
level
blood
pressur
drop
anim
becom
moribund
heart
rate
variabl
standard
deviat
heart
rate
alter
late
infect
recent
develop
telemetri
devic
aid
plethysomographi
measur
respiratori
minut
volum
accur
deliveri
present
dose
aerosol
exposur
hendra
nipah
viru
unusu
within
paramyxovirida
famili
given
infect
larg
rang
mammalian
host
virus
group
genu
henipaviru
natur
reservoir
virus
fruit
bat
genu
pteropu
hendra
nipah
abil
caus
sever
diseas
human
potenti
high
case
fatal
rate
outbreak
caus
nipah
viru
recogn
malaysia
singapor
bangladesh
india
hendra
outbreak
yet
report
outsid
australia
hendra
first
member
genu
identifi
initi
associ
acut
respiratori
diseas
hors
human
case
link
transmiss
close
contact
infect
hors
confirm
case
direct
transmiss
human
human
bat
human
nipah
distinct
abl
transmit
human
although
exact
rout
unknown
viru
suscept
ph
temperatur
desicc
thu
close
contact
hypothes
need
success
transmiss
virus
tropism
neurolog
respiratori
tract
hendra
viru
incub
period
day
mark
flulik
ill
symptom
initi
stage
includ
myalgia
headach
lethargi
sore
throat
vomit
diseas
progress
continu
pneumon
encephalit
manifest
person
succumb
multiorgan
failur
nipah
viru
incub
period
day
week
much
like
hendra
first
sign
diseas
nondescript
sever
neurolog
symptom
subsequ
develop
includ
enceph
seizur
progress
coma
within
h
survivor
infect
typic
make
full
recoveri
howev
suffer
perman
sequela
includ
persist
convuls
time
approv
vaccin
antivir
treatment
pure
support
anim
model
use
test
novel
vaccin
therapeut
also
deduc
earli
event
diseas
observ
human
case
termin
stage
best
small
anim
repres
syrian
golden
hamster
due
high
suscept
henipavirus
clinic
sign
upon
infect
recapitul
diseas
cours
human
includ
acut
enceph
respiratori
distress
challeng
anim
die
xi
viral
diseas
vivo
model
viral
diseas
affect
human
within
day
postinfect
progress
diseas
timelin
highli
depend
dose
rout
infect
intranas
inocul
lead
imbal
limb
paralysi
lethargi
breath
difficulti
wherea
intraperiton
result
tremor
paralysi
within
h
death
viru
detect
lung
brain
spleen
kidney
heart
spinal
cord
urin
brain
affect
organ
model
use
vaccin
passiv
protect
studi
guinea
pig
model
wide
use
due
lack
respiratori
diseas
upon
challeng
inocul
hendra
viru
via
subcutan
rout
lead
gener
vascular
diseas
mortal
clinic
sign
appar
day
postinfect
death
occur
within
day
cn
involv
higher
inocula
associ
develop
enceph
lesion
intraderm
intranas
inject
lead
diseas
although
anim
abl
seroconvert
upon
challeng
inoculum
sourc
affect
clinic
progress
nipah
viru
challeng
develop
diseas
upon
intraperiton
inject
result
weight
loss
transient
fever
day
viru
shed
urin
found
present
brain
spleen
lymph
node
ovari
uteru
urinari
bladder
ferret
display
clinic
diseas
seen
hamster
model
human
case
upon
inocul
oronas
rout
ferret
develop
sever
pulmonari
neurolog
diseas
within
day
includ
fever
cough
dyspnea
lesion
develop
ferret
brain
lesser
degre
seen
human
cat
also
use
anim
model
henipavirus
diseas
symptom
depend
upon
rout
infect
incub
period
day
lead
respiratori
neurolog
symptom
model
proven
use
vaccin
challeng
model
squirrel
agm
repres
nhp
model
within
squirrel
monkey
nipah
viru
introduc
either
intranas
iv
rout
subsequ
lead
clinic
sign
similar
human
although
intranas
challeng
result
milder
diseas
upon
challeng
anim
develop
diseas
manifest
includ
anorexia
dyspnea
acut
respiratori
syndrom
neurolog
involv
character
uncoordin
motor
skill
loss
conscious
coma
viral
rna
detect
lung
brain
liver
kidney
spleen
lymph
node
found
upon
iv
challeng
agm
found
consist
model
virus
intratrach
inocul
virus
result
mortal
death
within
day
postinfect
hendra
nipah
respect
anim
develop
sever
respiratori
neurolog
diseas
gener
vascul
reservoir
virus
grayhead
fruit
bat
experiment
challeng
due
statu
host
organ
henipavirus
bat
develop
clinic
diseas
howev
hendra
viru
detect
kidney
heart
spleen
fetal
tissu
nipah
viru
locat
urin
pig
investig
model
develop
respiratori
diseas
upon
infect
nipah
hendra
oral
inocul
produc
clinic
diseas
subcutan
inject
repres
success
rout
infect
live
viru
isol
oropharynx
earli
day
postinfect
nipah
also
transmit
pig
nipah
abl
induc
neurolog
symptom
pig
even
though
viru
present
neurolog
tissu
regardless
symptom
within
pig
model
seem
nipah
greater
tropism
respiratori
tract
hendra
neurolog
system
hors
also
abl
develop
sever
respiratori
tract
infect
accompani
fever
gener
weak
upon
exposur
nipah
hendra
oronas
inocul
led
system
diseas
viral
rna
detect
nasal
swab
within
day
anim
die
within
day
postexposur
found
interstiti
pneumonia
necrosi
alveoli
viru
could
detect
major
system
mice
rat
rabbit
chicken
dog
test
found
nonpermiss
infect
suckl
balbc
mice
succumb
infect
viru
inocul
intracrani
embryon
chicken
egg
inocul
nipah
viru
lead
univers
fatal
diseas
within
day
postinfect
respiratori
syncyti
viru
respons
lower
respiratori
tract
infect
million
children
age
year
turn
result
three
million
hospit
approxim
death
within
unit
state
hospit
cost
alon
amount
million
dollar
outbreak
common
winter
viru
transmit
larg
respiratori
droplet
replic
initi
within
nasopharynx
spread
lower
respiratori
tract
incub
viru
day
respiratori
syncyti
viru
highli
virul
lead
asymptomat
infect
diseas
manifest
highli
depend
upon
age
individu
primari
infect
neonat
produc
nonspecif
symptom
includ
overal
failur
thrive
apnea
feed
difficulti
infant
present
mild
upper
respiratori
tract
diseas
could
develop
bronchiol
bronchopneumonia
contract
viru
age
result
increas
chanc
develop
childhood
asthma
young
children
develop
recurr
wheez
wherea
adult
exacerb
previou
respiratori
condit
common
clinic
symptom
runni
nose
sneez
cough
accompani
fever
mortal
rate
hospit
children
greatest
burden
diseas
seen
vaccin
avail
ribavirin
usag
recommend
routin
treatment
anim
model
develop
hope
formul
effect
safe
vaccin
unlik
formalininactiv
respiratori
syncyti
viru
vaccin
firsv
vaccineinduc
sever
respiratori
ill
infant
receiv
vaccin
subsequ
infect
live
viru
mice
use
model
diseas
although
high
intranas
inocul
need
achiev
clinic
symptom
strain
choic
crucial
reproduc
physiolog
relev
respons
age
affect
primari
diseas
manifest
howev
play
role
later
sequela
show
increas
airway
hyperreact
primari
infect
produc
increas
breath
airway
obstruct
viru
detect
earli
day
reach
maximum
titer
day
postinfect
clinic
ill
defin
mous
weight
loss
ruffl
fur
oppos
runni
nose
sneez
cough
seen
human
cotton
rat
use
given
small
anim
diseas
model
viru
abl
replic
high
titer
within
lung
detect
upper
lower
airway
intranas
inocul
report
viral
replic
greater
rat
model
mous
model
rat
develop
mildtomoder
bronchiol
pneumonia
although
age
seem
factor
clinic
outcom
report
older
rat
tend
take
longer
achiev
viral
clearanc
viral
load
peak
fifth
day
drop
level
detect
histopatholog
lung
seem
similar
human
infect
model
limit
usag
model
human
immun
respons
infect
challeng
viru
creat
respons
wherea
human
tend
skew
toward
firsv
diseas
recapitul
upon
challeng
live
viru
vaccin
twice
firsv
chinchilla
challeng
experiment
via
intranas
inocul
viru
permiss
within
nasopharynx
eustachian
tube
anim
display
acut
respiratori
tract
infect
model
thought
use
studi
mucos
immun
infect
chimpanze
permiss
replic
clinic
symptom
respiratori
syncyti
viru
includ
rhinorrhea
sneez
cough
adult
squirrel
monkey
newborn
rhesu
macaqu
infant
cebu
monkey
also
challeng
exhibit
diseas
symptom
high
level
viral
replic
bonnet
monkey
also
test
found
develop
inflammatori
respons
day
viral
rna
detect
bronchial
alveolar
cell
chimpanze
model
proven
use
vaccin
studi
sheep
also
challeng
experiment
sinc
develop
respiratori
diseas
expos
ovin
respiratori
syncyti
viru
lamb
also
found
suscept
human
respiratori
syncyti
infect
inocul
intratrach
lamb
develop
upper
respiratori
tract
infect
cough
day
lamb
went
develop
lower
respiratori
diseas
includ
bronchiol
pneumonia
resolv
within
day
cours
diseas
viral
replic
peak
day
rapidli
declin
studi
respiratori
diseas
sheep
benefici
given
share
structur
featur
human
influenza
virus
consist
three
type
influenza
b
c
base
antigen
differ
influenza
classifi
subtyp
ha
na
subtyp
known
season
influenza
common
infect
usual
caus
selflimit
febril
ill
upper
respiratori
symptom
malais
resolv
within
day
rate
infect
estim
gener
popul
result
billion
dollar
loss
annual
medic
cost
reduc
workforc
product
approxim
peopl
unit
state
die
year
season
influenza
thu
vaccin
therapeut
play
critic
role
control
infect
develop
use
anim
model
ongo
influenza
viru
replic
upper
lower
airway
peak
approxim
h
postexposur
infect
sever
infant
children
age
year
peopl
age
year
immunocompromis
individu
viral
pneumon
pneumonia
develop
bacteri
superinfect
result
pneumonia
sepsi
pneumonia
secondari
bacteri
infect
streptococcu
pneumonia
streptococcu
pyrogen
neisseria
meningitid
rare
staphylococcu
aureu
common
viral
pneumonia
influenza
account
approxim
influenzaassoci
fatal
death
often
due
ard
occur
earli
day
onset
symptom
lung
histopatholog
sever
case
may
includ
dad
alveolar
edema
damag
hemorrhag
fibrosi
inflamm
avian
strain
influenza
lethal
rate
approxim
known
case
like
viru
preferenti
bind
cell
lower
respiratori
tract
thu
potenti
global
spread
major
concern
frequent
use
anim
model
influenza
infect
includ
mice
ferret
nhp
thorough
guid
work
mous
guinea
pig
ferret
cynomolgu
model
publish
kroez
et
al
lethal
rate
vari
viru
strain
use
without
adapt
dose
rout
inocul
age
genet
background
anim
variou
anim
model
captur
differ
diseas
caus
influenza
benign
sever
superinfect
sepsi
sever
ard
neurolog
manifest
also
model
use
season
avian
strain
model
develop
studi
transmiss
import
understand
potenti
lethal
strain
spread
among
human
mous
model
influenza
infect
predict
antivir
activ
tissu
tropism
human
use
test
evalu
vaccin
inocul
intranas
rout
use
approxim
ml
inoculum
nare
anesthet
mice
exposur
may
also
small
particl
aerosol
contain
influenza
mmad
mm
inbr
strain
suscept
particularli
frequent
use
balbc
follow
mice
male
femal
equival
diseas
influenza
gener
infecti
younger
g
mice
mice
somewhat
limit
use
character
immun
respons
influenza
mice
lack
mxa
gene
import
part
human
innat
immun
respons
influenza
infect
mous
homolog
mxa
defect
inbr
mous
strain
weight
loss
reduc
weight
gain
decreas
activ
huddl
ruffl
fur
increas
respir
common
clinic
sign
virul
strain
mice
may
requir
euthanasia
earli
h
postexposur
mortal
occur
day
postexposur
accompani
decreas
rectal
temperatur
puls
oximet
read
measur
blood
gase
oxygen
satur
also
use
determin
impact
influenza
infect
respiratori
function
viru
isol
bronchial
lavag
fluid
throughout
infect
tissu
euthanasia
influenza
strain
mildtomoder
pathogen
diseas
nonleth
viru
replic
detect
within
lung
usual
organ
increas
serum
lung
weight
also
frequent
present
howev
mice
infect
influenza
develop
fever
dyspnea
nasal
exud
sneez
cough
mice
experiment
infect
influenza
b
viru
gener
requir
adapt
produc
clinic
sign
mice
express
receptor
influenza
attach
respiratori
tract
howev
distribut
vari
sa
predomin
sa
subtyp
usual
need
adapt
mice
virus
requir
adapt
adapt
mice
infect
intratrach
intranas
viru
isol
lung
reinfect
mice
process
repeat
number
time
adapt
influenza
strain
produc
sever
diseas
system
spread
neurotrop
howev
pandem
influenza
viru
caus
lethal
infect
without
adapt
infect
mice
result
viremia
viral
replic
multipl
organ
system
sever
lung
patholog
fulmin
diffus
interstiti
pneumonia
pulmonari
edema
high
level
proinflammatori
cytokin
mark
lymphopenia
human
virul
attribut
damag
caus
overact
host
immun
respons
addit
mice
infect
influenza
produc
sever
lung
patholog
oxygen
satur
level
decreas
increas
pneumonia
superinfect
model
subleth
dose
influenza
given
mice
follow
day
later
intranas
inocul
subleth
dose
bacteri
strain
pneumonia
pyrogen
morbid
character
inflamm
lung
bacteremia
begin
coupl
day
superinfect
may
continu
week
least
one
transmiss
model
also
develop
mice
influenza
transmiss
rate
among
cage
mate
achiev
infect
aerosol
rout
cocag
h
domest
ferret
mustela
putoriu
furo
frequent
anim
speci
choic
influenza
anim
studi
suscept
clinic
sign
peak
viru
shed
kinet
transmiss
local
express
cytokin
mrna
patholog
resembl
human
ferret
also
airway
morpholog
respiratori
cell
type
distribut
influenza
receptor
sa
sa
within
airway
similar
human
influenza
first
isol
ferret
infect
intranas
throat
wash
human
harbor
infect
ferret
model
sinc
use
test
efficaci
vaccin
therapeut
treatment
perform
influenza
studi
ferret
anim
serolog
neg
circul
influenza
virus
infect
anim
place
separ
room
uninfect
anim
anim
must
place
room
uninfect
ferret
handl
infect
ferret
anesthet
ferret
experiment
expos
influenza
intranas
inocul
ml
contain
approxim
egg
dropwis
nostril
influenza
type
b
natur
infect
ferret
result
acut
ill
usual
last
day
mildli
moder
virul
strain
ferret
suscept
influenza
influenza
b
strain
also
suscept
avian
influenza
strain
without
adapt
virul
degre
pneumon
caus
differ
influenza
subtyp
strain
vari
mild
sever
gener
mirror
seen
human
nonadapt
mildtomoder
virul
ferret
strain
low
virul
predomin
replic
nasal
turbin
clinic
sign
diseas
indic
similar
human
mild
respiratori
diseas
sneez
nasal
secret
contain
viru
fever
weight
loss
high
viral
titer
inflammatori
infiltr
airway
bronchiti
pneumonia
replic
upper
lower
airway
associ
sever
diseas
greater
mortal
addit
increas
express
proinflammatori
mediat
reduc
express
antiinflammatori
mediat
lower
respiratori
tract
ferret
correl
sever
diseas
lethal
outcom
ferret
develop
sever
lethargi
greater
ifn
respons
transient
lymphopenia
replic
respiratori
tract
brain
organ
old
new
world
primat
suscept
influenza
infect
advantag
ferret
mous
model
defici
vaccin
studi
lack
correl
hemagglutin
inhibit
old
world
primat
cynomolgu
macaqu
fasciculari
frequent
use
studi
vaccin
antivir
drug
therapi
infect
cyno
similar
human
cyno
develop
fever
ard
upon
intranas
inocul
necrot
bronchial
interstiti
pneumonia
nhp
challeng
multipl
rout
ocular
nasal
tracheal
simultan
pfu
per
site
viru
antigen
primarili
local
tonsil
pulmonari
tissu
infect
cyno
result
fever
lethargi
nasal
discharg
anorexia
weight
loss
nasal
tracheal
wash
patholog
histopatholog
chang
alveolar
bronchial
inflamm
caus
high
mortal
rate
due
aberr
immun
respons
ard
lethal
human
lethal
ard
mortal
also
occur
pathogen
strain
nhp
show
reduc
suscept
less
virul
strain
influenzainfect
rhesu
macaqu
repres
mild
diseas
model
pathogenesi
vaccin
therapeut
efficaci
studi
nhp
model
includ
influenza
infect
pigtail
macaqu
mild
diseas
model
infect
new
world
primat
squirrel
cebu
monkey
rat
sd
inocul
ratadapt
develop
inflammatori
infiltr
cytokin
bronchoalveolar
lavag
fluid
lethal
histopatholog
chang
addit
influenza
transmiss
model
develop
guinea
pig
altern
ferret
cotton
rat
sigmodon
hispidu
use
test
vaccin
therapeut
limit
number
studi
cotton
rat
advantag
mice
immun
system
similar
human
includ
presenc
mx
gene
influenza
virus
adapt
nasal
pulmonari
tissu
cotton
rat
infect
unregul
cytokin
lung
viral
load
peak
h
postexposur
viru
clear
lung
day
nare
day
anim
bronchial
alveolar
damag
pneumonia
week
also
aureu
superinfect
model
cotton
rat
coinfect
result
bacteremia
high
bacteri
load
lung
peribronchiol
pneumon
alveol
hypothermia
higher
mortal
domest
pig
influenza
model
develop
vaccin
studi
swine
flu
pig
suscept
natur
natur
intermedi
host
readili
suscept
although
pig
infect
influenza
may
fever
anorexia
respiratori
sign
dyspnea
cough
mortal
rare
size
space
requir
make
anim
difficult
work
although
develop
minipig
ellegaard
gottingen
model
may
provid
easiertous
altern
incub
period
anim
exhibit
sign
fever
hepat
abort
hallmark
diagnost
sign
known
among
farmer
mosquito
vector
unpasteur
milk
aerosol
infect
anim
bodi
fluid
direct
contact
infect
anim
import
rout
transmiss
human
day
incub
period
rvfv
caus
wide
rang
sign
symptom
human
rang
asymptomat
sever
diseas
hepat
vision
loss
enceph
hemorrhag
fever
depend
sever
diseas
symptom
start
hospit
patient
might
die
day
day
diseas
onset
hepat
failur
renal
failur
dissemin
intravascular
coagul
dic
enceph
demonstr
within
patient
postmortem
examin
mice
one
suscept
anim
speci
rvfv
infect
subcutan
intraperiton
rout
infect
caus
acut
hepat
lethal
enceph
late
stage
diseas
mice
mice
start
exhibit
sign
decreas
activ
ruffl
fur
day
postexposur
immedi
sign
observ
becom
letharg
gener
die
day
postexposur
ocular
diseas
hemorrhag
form
diseas
observ
mice
model
far
increas
viremia
tissu
tropism
report
mice
increas
liver
enzym
lymphopenia
observ
sick
mice
rat
gerbil
also
suscept
rvfv
infect
rat
suscept
depend
rat
strain
use
challeng
model
also
note
age
depend
suscept
rat
although
wistarfurth
brown
norway
strain
young
rat
highli
suscept
rvfv
infect
fisher
buffalo
lewi
strain
old
rat
demonstr
resist
infect
similar
patholog
chang
liver
damag
encephalopathi
observ
rat
mice
liver
involv
gerbil
model
anim
die
sever
enceph
mortal
rate
depend
strain
use
dose
given
gerbil
similar
rat
model
suscept
gerbil
also
depend
age
far
studi
show
rvfv
caus
uniform
lethal
nhp
model
intraperiton
intranas
iv
aerosol
rout
use
develop
nhp
model
rhesu
macaqu
cynomolgu
macaqu
african
monkey
south
american
monkey
nhp
speci
use
effort
monkey
show
varieti
sign
rang
febril
diseas
hemorrhag
diseas
mortal
tempor
viremia
increas
coagul
paramet
pt
aptt
decreas
platelet
sign
observ
nhp
anim
succumb
diseas
show
similar
pathogenesi
seen
human
patholog
chang
liver
hemorrhag
diseas
ocular
involv
model
recent
smith
et
al
compar
iv
intranas
subcutan
rout
infect
common
marmoset
rhesu
macaqu
marmoset
suscept
rvfv
infect
rhesu
macaqu
mark
viremia
acut
hepat
late
onset
enceph
increas
liver
enzym
observ
speci
necropsi
result
show
enlarg
liver
marmoset
expos
iv
subcutan
rout
although
gross
lesion
brain
marmoset
histopatholog
show
enceph
brain
intranas
challeng
marmoset
crimeancongo
hemorrhag
fever
viru
cchfv
gener
circul
natur
unnot
enzoot
tickvertebratetick
cycl
similar
zoonot
agent
seem
produc
littl
diseas
natur
host
caus
sever
diseas
human
cchfv
transmit
human
ixodid
tick
direct
contact
sick
animalshuman
bodi
fluid
animalshuman
incub
prehemorrhag
hemorrhag
convalesc
four
phase
diseas
seen
human
incub
period
last
day
prehemorrhag
phase
patient
show
sign
nonspecif
flulik
diseas
approxim
week
hemorrhag
period
result
circulatori
shock
dic
patient
year
sever
attempt
made
establish
anim
model
cchf
adult
mice
guinea
pig
hamster
rat
rabbit
sheep
nhp
etc
recent
anim
manifest
diseas
newborn
mous
infant
mice
infect
cchfv
intraperiton
caus
fatal
around
day
postinfect
pathogenesi
studi
show
viru
replic
first
detect
liver
subsequ
spread
blood
serum
viru
detect
late
diseas
cours
tissu
includ
heart
day
brain
day
recent
studi
use
knockout
adult
mice
success
develop
lethal
small
anim
model
cchfv
infect
bent
et
al
infect
knockout
mice
intraperiton
rout
model
sign
fever
leucopenia
thrombocytopenia
viremia
elev
liver
enzym
proinflammatori
cytokin
mice
moribund
succumb
diseas
day
postexposur
second
model
develop
use
ifnalphabeta
ifnab
receptor
knockout
mice
similar
observ
made
model
knockout
mous
model
anim
moribund
die
day
exposur
high
viremia
level
liver
spleen
laboratori
anim
includ
nhp
show
littl
sign
infect
diseas
infect
cchfv
butenko
et
al
use
agm
cercopithecu
aethiop
experiment
cchfv
infect
except
one
monkey
fever
day
postinfect
anim
exhibit
sign
diseas
antibodi
viru
detect
three
five
monkey
includ
one
fever
fagbami
et
al
infect
two
pata
monkey
cercopithecu
erythrocebuserythrocebu
one
guinea
baboon
papio
papio
cchfv
although
three
anim
low
level
viremia
day
inocul
baboon
serum
neutral
antibodi
activ
day
postinfect
similar
result
obtain
hors
donkey
use
experiment
cchfv
infect
donkey
develop
lowlevel
viremia
hors
develop
littl
viremia
high
level
virusneutr
antibodi
remain
stabl
least
month
studi
suggest
hors
may
use
laboratori
obtain
serum
diagnost
possibl
therapeut
purpos
shepherd
et
al
infect
speci
small
african
wild
mammal
laboratori
rabbit
guinea
pig
syrian
hamster
cchfv
although
scrub
hare
lepu
saxatili
cape
ground
squirrel
xeru
inauri
red
veld
rat
aethomi
chrysophilu
whitetail
rat
mystromi
pumilio
guinea
pig
viremia
south
african
hedgehog
atelerix
frontali
highveld
gerbil
tatera
brantsii
namaqua
gerbil
desmodillu
auriculari
two
speci
multimamm
mous
mastomi
natalensi
coucha
syrian
hamster
neg
speci
regardless
viremia
level
develop
antibodi
respons
cchfv
iv
intracrani
infect
anim
show
onset
viremia
earlier
infect
subcutan
intraperiton
rout
genu
hantaviru
uniqu
among
famili
bunyavirida
transmit
arthropod
vector
rather
rodent
rodent
famili
murida
primari
reservoir
hantavirus
infect
host
anim
develop
persist
infect
typic
asymptomat
transmiss
achiev
inhal
infect
rodent
saliva
fece
urin
human
infect
normal
trace
rural
set
activ
farm
land
develop
hunt
camp
possibl
site
transmiss
rodent
control
primari
rout
prevent
virus
tropism
endotheli
cell
within
microvasculatur
lung
two
distinct
clinic
diseas
infect
yield
hemorrhag
fever
renal
syndrom
hfr
due
infect
old
world
hantavirus
hantaviru
pulmonari
syndrom
hp
caus
new
world
hantavirus
hfr
mainli
seen
outsid
america
associ
hantavirus
dobravabelgrad
also
known
dobrava
hantaan
puumala
seoul
incub
last
two
three
week
present
flulik
initi
stage
develop
hemorrhag
manifest
ultim
renal
failur
thrombocytopenia
subsequ
develop
progress
shock
approxim
patient
overal
mortal
rate
infect
dobrava
hantaan
virus
typic
link
develop
sever
diseas
hp
first
diagnos
within
southwestern
unit
state
healthi
young
adult
becam
suddenli
ill
progress
sever
respiratori
distress
shock
etiolog
agent
respons
outbreak
identifi
sin
nombr
viru
viru
still
lead
caus
within
na
hp
hp
due
hantavirus
report
argentina
bolivia
brazil
canada
chile
french
guiana
panama
paraguay
uruguay
first
report
hp
main
recent
document
and
viru
first
identifi
outbreak
chile
argentina
hantaviru
distinct
transmit
human
fulmin
diseas
lethal
observ
hfr
mortal
rate
four
phase
diseas
includ
prodrom
pulmonari
cardiac
depress
hematolog
manifest
incub
typic
occur
day
exposur
unlik
hfr
renal
failur
major
contribut
factor
diseas
short
prodrom
phase
give
way
cardiopulmonari
involv
accompani
cough
gastrointestin
symptom
point
individu
typic
admit
hospit
pulmonari
function
hinder
continu
suffer
within
h
cardiopulmonari
involv
interstiti
edema
airspac
diseas
normal
follow
fatal
case
cardiogen
shock
note
vaccin
develop
hamper
vast
divers
hantavirus
limit
number
outbreak
syrian
golden
hamster
wide
use
small
anim
model
hantaviru
infect
hamster
inocul
intramuscularli
passag
and
viral
strain
die
within
day
postinfect
clinic
sign
appear
h
death
point
hamster
moribund
respiratori
distress
mortal
dose
depend
high
inoculum
lead
shorter
incub
death
studi
hamster
inocul
passag
sin
nombr
isol
hamster
develop
symptom
cours
observ
although
antibodi
respons
viru
dose
depend
determin
via
enzymelink
immunosorb
assay
hamster
infect
and
viru
found
signific
histopatholog
chang
lung
liver
spleen
interstiti
pneumonia
intraalveolar
edema
infecti
viru
could
recov
organ
viremia
began
day
last
day
postinfect
infect
hamster
and
viru
yield
similar
clinic
diseas
progress
seen
human
hp
includ
rapid
progress
death
fluid
pleural
caviti
signific
histopatholog
chang
lung
spleen
major
deviat
hamster
model
detect
infecti
viru
within
liver
lethal
diseas
induc
newborn
mice
recapitul
clinic
symptom
observ
human
diseas
adult
mice
expos
hantaan
viru
lead
fatal
diseas
depend
upon
viral
strain
rout
infect
diseas
progress
mark
neurolog
pulmonari
manifest
mirror
human
diseas
knockout
mice
lace
ifnab
found
highli
suscept
hantaan
viru
infect
studi
look
panel
laboratori
strain
mice
mice
found
suscept
passag
hantaan
viral
strain
inject
intraperiton
anim
progress
neurolog
manifest
includ
paralys
convuls
succumb
infect
within
h
postinfect
clinic
diseas
markedli
differ
observ
human
case
nhp
challeng
new
world
hantavirus
howev
clinic
sign
report
cynomolgu
monkey
challeng
clinic
isol
puumala
viru
develop
mild
diseas
challeng
and
viru
cynomolgu
macaqu
iv
aerosol
exposur
led
sign
diseas
anim
display
drop
total
lymphocyt
within
day
postinfect
aerosol
exposur
led
monkey
iv
inject
monkey
develop
viremia
infecti
viru
could
isol
anim
famili
arenavirida
compos
two
serogroup
old
world
arenavirus
includ
lassa
fever
viru
lymphocyt
choriomening
viru
new
world
virus
pichind
viru
junin
viru
virus
share
common
clinic
manifest
lassa
fever
viru
endem
part
west
africa
outbreak
typic
seen
dri
season
januari
april
viru
respons
infect
per
year
lead
approxim
death
outbreak
report
guinea
sierra
leon
liberia
nigeria
central
african
republ
howev
case
sprung
germani
netherland
unit
kingdom
unit
state
due
transmiss
travel
commerci
airlin
transmiss
viru
typic
occur
via
rodent
particular
multimamm
rat
mastomi
speci
complex
human
becom
infect
inhal
aerosol
viru
eat
contamin
food
also
note
humantohuman
transmiss
direct
contact
infect
secret
needlestick
injuri
major
infect
asymptomat
howev
sever
diseas
occur
individu
incub
period
day
initi
onset
character
flulik
ill
follow
diarrheal
diseas
progress
hemorrhag
symptom
includ
encephalopathi
enceph
mening
third
patient
develop
deaf
earli
phase
diseas
perman
third
affect
overal
fatal
howev
admit
hospit
approv
vaccin
besid
support
measur
ribavirin
effect
start
within
day
primari
anim
model
use
studi
lassa
fever
rhesu
macaqu
aerosol
infect
lymphocyt
choriomening
viru
use
model
lassa
fever
rhesu
cynomolgu
monkey
expos
viru
develop
diseas
rhesu
close
mirror
diseas
cours
histopatholog
observ
human
infect
iv
intragastr
inocul
viru
led
sever
dehydr
erythemat
skin
submucos
edema
necrot
foci
buccal
caviti
respiratori
distress
liver
sever
affect
viru
depict
measur
liver
enzym
ast
alt
diseas
dosedepend
iv
intramuscular
subcutan
inocul
requir
least
amount
viru
induc
diseas
aerosol
infect
eat
contamin
food
could
also
use
mimic
natur
rout
infect
within
model
nhp
becom
virem
day
clinic
manifest
present
day
death
typic
occur
within
day
intramuscular
inject
lassa
viru
cynomolgu
monkey
also
produc
neurolog
diseas
due
lesion
within
cn
pathogen
seen
select
case
human
lassa
fever
marmoset
model
recent
defin
use
subcutan
inject
lassa
fever
viru
viru
initi
detect
day
viremia
achiev
day
liver
enzym
elev
enlarg
liver
note
upon
autopsi
gradual
reduct
platelet
interstiti
pneumon
diagnos
minor
anim
physiolog
sign
seen
fatal
human
case
mice
develop
fatal
neurolog
disord
upon
intracerebr
inocul
lassa
although
outcom
infect
complet
depend
upon
major
histocompat
complex
mhc
background
age
anim
along
rout
inocul
guinea
pig
inbr
strain
found
highli
suscept
lassa
viru
infect
outbre
hartley
strain
less
suscept
thu
strain
prefer
model
given
assur
lethal
clinic
manifest
mirror
seen
human
rhesu
infect
pichind
viru
passag
guinea
pig
also
use
diseas
sign
includ
fever
weight
loss
vascular
collaps
eventu
death
guinea
pig
excel
model
given
result
similar
diseas
pattern
human
also
viral
distribut
similar
along
histopatholog
immun
respons
infect
hamster
cotton
rat
isol
pirit
viru
similar
character
human
nhp
guinea
pig
model
viru
inject
intraperiton
result
anim
becom
letharg
anorex
within
day
viru
first
detect
day
reach
maximum
titer
within
day
neurolog
symptom
began
appear
time
anim
die
day
pneumon
pulmonari
hemorrhag
edema
also
present
result
recapitul
nonadapt
pichind
viru
global
diarrheal
diseas
lead
caus
death
rotaviru
one
main
etiolog
agent
respons
accord
world
health
organ
rotaviru
alon
respons
third
hospit
relat
diarrhea
death
per
year
viru
stabl
due
threelay
capsid
allow
transmit
via
oralfec
rout
deposit
small
intestin
rotaviru
highli
contagi
virus
need
caus
symptomat
diseas
host
determin
greatest
influenc
clinic
outcom
age
neonat
typic
asymptomat
suggest
due
exist
matern
antibodi
henc
suscept
age
group
month
year
coincid
drop
protect
antibodi
within
age
rang
children
develop
noninflammatori
diarrhea
viru
replic
intestin
villu
enterocyt
result
destruct
malabsorpt
need
electrolyt
nutrient
symptom
diseas
includ
wateri
nonbloodi
diarrhea
vomit
fever
potenti
dehydr
last
week
short
episod
viremia
cours
infect
mice
use
infect
diseas
model
depend
upon
age
challeng
mice
day
old
develop
diseas
wherea
older
mice
abl
clear
infect
onset
symptom
halt
studi
activ
vaccin
diseas
infect
model
adult
mous
model
cours
infect
monitor
via
viral
shed
within
stool
infant
mice
specif
balbc
receiv
oral
inocul
clinic
strain
viru
develop
diarrhea
within
h
postinfect
expos
develop
symptom
within
h
postinfect
symptom
last
day
mortal
viral
shed
peak
h
last
day
note
histopatholog
chang
within
small
intestin
local
villi
revers
within
adult
mous
model
oral
inocul
mous
rotaviru
strain
show
viral
shed
day
last
day
postinfect
mous
model
use
studi
correl
protect
therapeut
efficaci
includ
gastrogard
rat
also
use
diseas
model
depend
upon
strain
rat
suckl
fischer
rat
expos
simian
strain
rotaviru
oral
rat
suscept
diarrheal
diseas
till
day
old
age
determin
length
viral
shed
rat
mainli
use
studi
correct
formul
oral
rehydr
rodent
larg
enough
perform
situ
intestin
perfus
within
studi
rat
infect
rat
strain
rotaviru
orogastr
intub
within
h
postinfect
rat
develop
diarrhea
point
small
intestin
perfus
compar
differ
solut
oral
rehydr
gnotobiot
pig
also
use
given
infect
porcin
human
strain
suscept
develop
clinic
diseas
human
strain
week
age
allow
analysi
primari
immun
respons
viru
given
receiv
transplacent
matern
antibodi
immun
compet
birth
anoth
advantag
model
gastrointestin
physiolog
mucos
immun
system
close
resembl
human
model
use
studi
correl
protect
gnotobiot
colostrumdepriv
calv
also
use
experiment
model
rotaviru
infect
abl
develop
diarrhea
shed
live
viru
gnotobiot
lamb
also
develop
clinic
diseas
upon
oral
inocul
clinic
strain
infant
baboon
agm
rhesu
macaqu
proven
infect
model
sever
measur
viral
shed
retrovirida
human
immunodefici
viru
type
lentivirus
subfamili
retrovirida
includ
human
immunodefici
viru
hiv
viru
infect
world
popul
greater
proport
infect
death
occur
subsaharan
africa
worldwid
approxim
million
death
per
year
children
transmiss
hiv
occur
exposur
infecti
bodi
fluid
two
speci
lower
infect
virul
confin
mostli
west
africa
vast
major
case
worldwid
hiv
target
thelper
cell
macrophag
dendrit
cell
acut
infect
occur
week
exposur
flulik
symptom
viremia
follow
chronic
infect
symptom
acut
phase
may
includ
fever
bodi
ach
nausea
vomit
headach
lymphadenopathi
pharyng
rash
sore
mouth
esophagu
tcell
activ
kill
hivinfect
cell
respons
antibodi
product
seroconvers
acquir
immun
defici
syndrom
aid
develop
tcell
declin
cell
per
microlit
thu
cellmedi
immun
becom
impair
person
suscept
opportunist
infect
certain
cancer
human
mice
creat
engraft
human
cell
tissu
scid
mice
critic
develop
mous
model
studi
hiv
infect
number
differ
human
mous
model
allow
studi
hiv
infect
context
intact
function
human
innat
adapt
immun
respons
scidhu
hiv
infect
model
proven
use
particularli
screen
antivir
therapeut
number
differ
human
mous
model
develop
studi
hiv
includ
hnog
nod
hnsg
nodscid
blt
nod
hnsg
blt
human
stem
cell
deriv
umbil
cord
blood
fetal
liver
use
human
infect
intraperiton
inject
success
littl
peripher
blood
engraft
vagin
rectal
transmiss
model
develop
blt
scidhu
mice
mice
harbor
human
bone
marrow
liver
thymu
tissu
viremia
occur
within
approxim
day
pi
mani
model
spleen
lymph
node
thymu
tissu
highli
posit
viru
similar
human
importantli
deplet
human
tcell
observ
blood
lymphoid
tissu
hivinfect
human
mice
least
mechan
pathogenesi
occur
hivinfect
human
also
occur
hivinfect
human
mous
model
advantag
model
mice
suscept
hiv
infect
thu
impact
drug
intend
viral
target
test
one
caveat
although
mice
common
mucos
immun
system
human
due
differ
distribut
addressin
thu
murin
mucos
immun
respons
hiv
reflect
human
number
import
nhp
model
human
hiv
infect
simian
immunodefici
viru
siv
infect
macaqu
wide
consid
best
platform
model
hiv
infect
human
importantli
nhp
similar
pharmacokinet
metabol
mucos
tcell
home
receptor
vascular
addressin
human
thu
although
correl
protect
hiv
still
complet
known
immun
respons
hiv
infect
vaccin
like
compar
model
mimic
infect
use
contamin
needl
iv
sexual
transmiss
vagin
rectal
matern
transmiss
utero
breast
milk
also
macaqu
model
studi
emerg
clinic
implic
hiv
drug
resist
model
routin
use
rhesu
macaqu
macaca
mulatta
cynomolgu
macaqu
macaca
fasiculari
pigtail
macaqu
macaca
nemestrina
anim
age
use
depend
need
studi
instanc
use
newborn
macaqu
may
practic
evalu
effect
prolong
drug
therapi
diseas
progress
howev
adult
nhp
frequent
use
studi
perform
anim
laboratori
nhp
must
simian
type
retroviru
free
siv
seroneg
siv
infect
pigtail
macaqu
use
model
hiv
peripher
nervou
system
patholog
wherein
axotomi
perform
regener
axon
studi
challeng
may
singl
high
dose
iv
infect
rhesu
macaqu
tcid
highli
pathogen
induc
aid
macaqu
within
month
mean
month
peak
viremia
occur
around
week
aid
model
often
defin
tcell
drop
baselin
valu
altern
repeat
lowdos
challeng
often
use
depend
requir
model
nhp
infect
hiv
develop
infect
clinic
diseas
cours
similar
human
siv
laboratoryengin
chimer
virus
simianhuman
immunodefici
viru
shiv
use
surrog
nhp
infect
pathogen
siv
may
develop
clinic
diseas
progress
aid
thu
use
pathogenesi
model
disadvantag
siv
ident
close
relat
howev
polymeras
region
siv
homolog
suscept
mani
revers
transcriptas
rt
proteas
inhibitor
siv
gener
suscept
nonnucleosid
inhibitor
thu
rt
usual
put
siv
studi
similar
hiv
polymeras
region
therefor
suscept
nucleosid
rt
integras
inhibit
nhp
infect
asymptomat
period
diseas
progress
resembl
aid
human
character
weight
losswast
tcell
deplet
addit
use
chemokin
receptor
coreceptor
similar
hiv
import
drug
target
entri
nhp
infect
shiv
strain
may
develop
aid
model
use
test
vaccin
efficaci
exampl
rtshiv
envshiv
use
test
evalu
drug
may
target
envelop
rt
respect
one
disadvantag
highli
virul
envshiv
p
use
coreceptor
note
envshiv
use
coreceptor
less
virul
viremia
develop
resolv
without
diseas
progress
simiantrop
st
contain
vif
gene
siv
infect
pigtail
macaqu
viru
result
viremia
detect
three
month
follow
clearanc
number
rout
use
siv
shiv
infect
nhp
iv
inocul
common
rout
mucos
rout
includ
vagin
rectal
intracolon
mucos
rout
requir
higher
onetim
dose
iv
rout
infect
vagin
rout
femal
macaqu
treat
depoprovera
estrogen
one
month
infect
synchron
menstrual
cycl
thin
epitheli
line
vagina
increas
suscept
infect
atraumat
vagin
instil
upon
vagin
instil
peak
viremia
seen
around
day
postexposur
copi
per
millilit
drop
thereaft
constant
level
rna
copi
per
millilit
day
beyond
anoth
exampl
investig
effect
vaccin
plu
vagin
microbicid
prevent
infect
rhesu
macaqu
vagin
infect
high
dose
exampl
intrarect
model
use
juvenil
yearold
pigtail
macaqu
challeng
intrarect
tcid
siv
studi
pathogenesi
relat
virul
factor
vpx
viremia
peak
approxim
day
copi
per
millilit
viral
rna
express
cell
mesenter
lymph
node
male
genit
tract
seen
viral
sanctuari
persist
high
level
hiv
shed
even
antiretrovir
therapi
better
understand
effect
highli
activ
antiretrovir
therapi
viru
tcell
male
genit
tract
adult
old
male
cynomolgu
macaqu
intraven
inocul
male
genit
tract
tissu
test
euthanasia
pcr
ihc
situ
hybrid
pediatr
model
develop
infant
rhesu
macaqu
infect
siv
allow
studi
impact
development
immunolog
differ
diseas
cours
importantli
mothertoinf
transmiss
model
also
develop
pregnant
femal
pigtail
macaqu
infect
second
trimest
mid
iv
rout
four
nine
infant
infect
one
utero
three
either
intrapartum
immedi
postpartum
nurs
model
use
studi
factor
involv
transmiss
underli
immunolog
nhp
infect
siv
shiv
routin
evalu
weight
loss
activ
level
stool
consist
appetit
viru
level
blood
tcell
popul
cytokin
chemokin
level
antibodi
respons
cytotox
tlymphocyt
respons
may
also
evalu
ultim
goal
hiv
vaccin
steril
immun
prevent
infect
howev
realist
result
may
reduc
sever
infect
perman
prevent
progress
strategi
includ
live
attenu
nonrepl
subunit
vaccin
variabl
efficaci
nhp
due
genet
host
mhc
terminalrepeat
retrotransposon
miniatur
trim
allel
differ
challeng
strain
challeng
rout
nhp
model
led
develop
antivir
treatment
effect
reduc
viral
load
inde
transmiss
hiv
among
human
one
prefer
variat
model
test
longterm
clinic
consequ
antivir
treatment
use
newborn
macaqu
treat
birth
onward
case
decad
unfortun
howev
success
nhp
studi
alway
translat
success
human
seen
recent
step
studi
use
adenovirusbas
vaccin
approach
vaccin
human
protect
may
even
suscept
hiv
viremia
reduc
infect
attenu
hope
regard
challeng
rout
iv
difficult
protect
mucos
use
worstcas
scenario
howev
efficaci
one
mucos
rout
usual
compar
mucos
rout
human
anim
papillomavirus
caus
benign
epitheli
prolifer
wart
malign
tumor
variou
tissu
infect
human
papillomavirus
hpv
differ
strain
caus
wart
skin
oropharynx
nasopharynx
larynx
anogenit
tissu
approxim
third
transmit
sexual
virul
subtyp
place
individu
high
risk
cervic
cancer
major
challeng
studi
virus
papillomavirus
gener
infect
speci
outsid
natur
host
caus
larg
spectrum
sever
thu
anim
model
identifi
suscept
hpv
howev
number
use
surrog
model
exist
use
anim
papillomavirus
natur
host
close
relat
speci
model
facilit
recent
develop
use
highli
effect
prophylact
hpv
vaccin
wild
cottontail
rabbit
sylvilagu
floridanu
natur
host
cottontail
rabbit
papillomaviru
crpv
viru
also
infect
domest
rabbit
oryctolagu
cuniculu
close
relat
speci
model
papilloma
rang
cutan
squamou
cell
carcinoma
one
end
spectrum
spontan
regress
lesion
result
crpv
domest
rabbit
typic
contain
infecti
viru
canin
oral
papillomaviru
copv
caus
florid
warti
lesion
mucosa
oral
caviti
within
week
postexposur
experiment
set
mucosatroph
natur
virus
result
oropharyng
papilloma
morpholog
similar
human
vagin
papilloma
caus
make
use
model
lesion
typic
spontan
regress
week
appear
model
therefor
use
understand
interplay
host
immun
defens
viral
pathogenesi
male
femal
beagl
age
week
year
histori
copv
typic
use
studi
infect
achiev
applic
ml
droplet
viru
extract
multipl
cm
scarifi
area
within
mucosa
upper
lip
anesthet
beagl
bovin
papillomaviru
bpv
wider
host
rang
papillomavirus
infect
fibroblast
cell
numer
ungul
infect
cattl
feed
bracken
fern
carcinogen
result
lesion
oral
esophag
mucosa
lack
detect
viral
dna
bpv
infect
cattl
result
rang
diseas
skin
wart
cancer
upper
gastrointestin
tract
urinari
bladder
papillomatosi
peni
teat
udder
final
sexual
transmit
papillomavirus
rhesu
macaqu
cynomolgu
macaqu
rhesu
papillomaviru
similar
associ
develop
cervic
cancer
mice
use
studi
diseas
caus
papillomavirus
unless
engraft
relev
tissu
often
use
look
immunogen
vaccin
herpesvirida
pleas
see
chapter
monkeypox
viru
mpxv
caus
diseas
anim
human
human
monkeypox
clinic
almost
ident
ordinari
smallpox
occur
mostli
rainforest
central
western
africa
viru
maintain
natur
rodent
reservoir
includ
squirrel
mpxv
discov
poxlik
diseas
outbreak
among
laboratori
java
macaqu
denmark
human
case
observ
outbreak
first
human
case
recogn
distinct
diseas
zair
present
drc
continu
occurr
smallpoxlik
ill
despit
erad
effort
smallpox
area
global
erad
campaign
extens
vaccin
central
africa
decreas
incid
human
monkeypox
absenc
immun
gener
born
sinc
time
increas
depend
bush
meat
result
renew
emerg
diseas
summer
wellknown
outbreak
midwest
first
occurr
monkeypox
diseas
unit
state
western
hemispher
among
report
case
human
case
laboratori
confirm
outbreak
determin
nativ
prairi
dog
cynomi
sp
hous
rodent
import
ghana
west
africa
primari
sourc
outbreak
viru
mainli
transmit
human
handl
infect
anim
direct
contact
infect
anim
bodi
fluid
lesion
persontoperson
spread
occur
larg
respiratori
droplet
direct
contact
clinic
featur
human
monkeypox
similar
ordinari
smallpox
incub
period
diseas
begin
fever
malais
headach
sore
throat
cough
main
sign
diseas
distinguish
monkeypox
smallpox
swollen
lymph
node
lymphaden
observ
patient
develop
rash
typic
maculopapular
rash
follow
prodrom
period
gener
last
day
averag
size
skin
lesion
cm
progress
lesion
follow
order
macul
papul
vesicl
pustul
umblic
scab
desquam
last
typic
week
fatal
rate
among
unvaccin
popul
death
gener
occur
second
week
diseas
mpxv
highli
pathogen
varieti
laboratori
anim
far
mani
anim
model
develop
use
differ
speci
differ
rout
exposur
tabl
unavail
variola
viru
develop
anim
model
result
diseas
manifest
human
similar
mpxv
one
pox
virus
use
heavili
develop
number
small
anim
model
via
differ
rout
exposur
wildderiv
inbr
mous
mous
prairi
dog
african
dormic
ground
squirrel
highli
suscept
mpxv
differ
exposur
rout
casteij
mice
one
inbr
mous
strain
test
suscept
mpxv
show
weight
loss
dosedepend
mortal
intranas
exposur
mpxv
studi
intraperiton
rout
challeng
indic
higher
suscept
mpxv
almost
less
compar
intranas
rout
scidbalbc
mice
also
suscept
intraperiton
challeng
rout
diseas
result
mortal
day
postinfect
similarli
mice
infect
intranas
mpxv
infect
result
weight
loss
mortal
day
postexposur
mice
model
mention
promis
screen
therapeut
pox
virus
test
addit
model
requir
advanc
develop
high
dose
mpxv
intraperiton
intranas
rout
caus
mortal
day
postexposur
day
postexposur
respect
ground
squirrel
diseas
progress
quickli
anim
letharg
moribund
day
postexposur
without
pox
lesion
respiratori
chang
comparison
studi
usa
mpxv
central
african
strain
mpxv
ground
squirrel
subcutan
rout
result
system
diseas
mortal
day
postexposur
diseas
resembl
hemorrhag
smallpox
nose
bleed
impair
coagul
paramet
hemorrhag
lung
anim
us
outbreak
viru
transmit
infect
prairi
dog
anim
model
recent
studi
much
use
test
therapeut
vaccin
compar
small
anim
model
studi
use
intranas
intraperiton
intraderm
rout
exposur
show
mpxv
highli
infecti
prairi
dog
use
west
african
mpxv
strain
intraperiton
rout
caus
sever
diseas
mortal
challeng
intranas
rout
anorexia
lethargi
common
sign
diseas
exposur
rout
contrast
intraperiton
rout
intranas
rout
exposur
caus
sever
pulmonari
edema
necrosi
lung
prairi
dog
splenic
necrosi
hepat
lesion
observ
intraperiton
infect
anim
recent
studi
hutson
et
al
use
intranas
intraderm
infect
west
african
congo
basin
strain
show
strain
rout
caus
smallpoxlik
diseas
longer
incub
period
gener
pox
lesion
therefor
model
use
test
therapeut
vaccin
pox
virus
african
dormous
suscept
mpxv
foodpad
inject
rout
intranas
rout
mice
exhibit
decreas
activ
hunch
postur
dehydr
conjunct
weight
loss
viral
dose
pfu
provid
mortal
mean
time
death
day
upper
gastrointestin
hemorrhag
hepatomegali
lymphadenopathi
hemorrhag
lung
observ
necropsi
hemorrhag
sever
organ
model
resembl
hemorrhag
smallpox
consid
limit
avail
ground
squirrel
african
dormic
lack
reagent
speci
resembl
hemorrhag
smallpox
diseas
model
attract
character
vaccin
countermeasur
test
studi
nhp
expos
mpxv
sever
differ
rout
develop
anim
model
mpxv
studi
use
aerosol
rout
exposur
observ
macaqu
mild
anorexia
depress
fever
lymphadenopathi
day
postexposur
complet
blood
count
clinic
chemistri
show
abnorm
similar
human
monkeypox
case
leukocytosi
thrombocytopenia
wholeblood
throat
swab
viral
load
peak
around
day
survivor
gradual
decreas
day
postexposur
dose
pfu
result
lethal
anim
wherea
dose
pfu
result
lethal
surviv
dose
depend
main
pitfal
model
lack
pox
lesion
high
dose
anim
develop
pox
lesion
succumb
diseas
low
challeng
dose
pox
lesion
observ
comparison
iv
model
mpxv
caus
dosedepend
diseas
nhp
given
iv
rout
studi
show
pfu
iv
challeng
result
system
diseas
fever
lymphadenopathi
maculapapular
rash
mortal
intratrach
infect
model
deposit
viru
trachea
deliv
directli
airway
without
regard
particl
size
physiolog
deposit
occur
process
inhal
skip
upper
respiratori
system
fibrinonecrot
bronchopneumonia
describ
anim
receiv
pfu
mpxv
intratrach
although
similar
challeng
dose
intratrach
mpxv
infect
result
similar
viremia
nhp
aerosol
rout
infect
time
first
peak
delay
day
intratrach
expos
macaqu
compar
aerosol
infect
amount
viru
detect
qpcr
approxim
lower
suggest
local
replic
promin
aerosol
deliveri
compar
intratrach
deliveri
intrabronchi
rout
exposur
result
pneumonia
nhp
delay
onset
clinic
sign
viremia
observ
diseas
progress
model
similar
aerosol
intratrach
rout
infect
model
number
pox
lesion
much
less
iv
rout
infect
model
major
downsid
iv
intratrach
intrabronchi
model
initi
infect
respiratori
tissu
incub
prodrom
phase
circumv
direct
inocul
viru
blood
stream
lung
import
limit
util
model
test
possibl
vaccin
treatment
efficaci
may
depend
protect
respiratori
mucosa
target
subsequ
earli
stage
infect
repres
challeng
model
although
aerosol
model
natur
rout
transmiss
human
variola
viru
varv
infect
secondari
rout
human
mpxv
infect
lack
pox
lesion
main
drawback
model
therefor
model
decid
use
test
medic
countermeasur
endpoint
biomark
initi
treatment
chosen
care
hepat
b
one
common
infect
worldwid
million
peopl
chronic
infect
case
per
year
liver
cancer
due
infect
viru
natur
infect
human
chimpanze
hepat
b
transmit
parenter
postnat
infect
mother
also
transmit
sexual
contact
iv
drug
use
blood
transfus
acupunctur
age
one
infect
dictat
risk
develop
chronic
diseas
acut
infect
adulthood
selflimit
result
flulik
symptom
progress
hepatocellular
involv
observ
develop
jaundic
clinic
symptom
last
week
resolv
acut
phase
life
time
immun
achiev
infect
develop
chronic
form
diseas
chronic
seriou
outcom
diseas
result
cirrhosi
liver
cancer
hepatocellular
carcinoma
time
like
develop
chronic
infect
individu
noncarri
viral
determin
cellular
transform
yet
determin
although
studi
involv
woodchuck
hepadna
viru
suggest
x
protein
may
respons
mani
individu
asymptomat
complic
emerg
relat
chronic
carriag
chimpanze
uniqu
strain
circul
within
popul
found
wildcaught
anim
africa
posit
hepat
b
antigen
natur
experiment
challeng
viru
follow
cours
human
diseas
howev
acut
model
diseas
date
use
chimpanze
provid
reliabl
method
ensur
plasma
vaccin
free
infecti
particl
anim
model
use
studi
new
therapeut
vaccin
chimpanze
especi
attun
studi
given
immun
respons
infect
directli
mirror
human
nhp
evalu
gibbon
orangutan
rhesu
monkey
although
anim
infect
hepat
b
none
develop
hepat
lesion
liver
damag
note
monitor
liver
enzym
mice
permiss
infect
thu
numer
transgen
human
line
express
hepat
b
protein
creat
facilit
usag
anim
model
includ
immunocompet
immunosuppress
host
caveat
mous
line
reproduc
acut
form
diseas
recent
entir
genom
hepat
b
transfer
immunocompet
mous
line
via
adenoviru
provid
model
persist
infect
hepat
b
also
studi
use
surrog
virus
natur
occur
mammalian
hepadna
virus
woodchuck
hepat
viru
found
induc
hepatocellular
carcinoma
within
popul
neonat
woodchuck
suscept
chronic
infect
major
differ
two
hepat
isol
rate
induc
cancer
almost
chronic
carrier
develop
hepatocellular
carcinoma
within
year
initi
infect
woodchuck
wherea
human
infect
take
much
longer
acut
infect
strongli
resembl
occur
cours
diseas
human
selflimit
acut
phase
result
transient
viremia
potenti
chronic
carriag
challeng
viru
neonat
lead
chronic
infect
adult
develop
acut
phase
diseas
close
relat
speci
woodchuck
marmota
himalayan
anim
also
suscept
woodchuck
hepadna
viru
upon
iv
inject
found
develop
acut
hepat
product
infect
hepat
depend
upon
hepat
b
undergo
replic
success
infect
human
host
two
mode
infect
possibl
virus
coinfect
person
simultan
infect
superinfect
chronic
carrier
hepat
b
subsequ
infect
hepat
coinfect
lead
similar
diseas
seen
hepat
b
alon
howev
superinfect
result
chronic
hepat
infect
sever
liver
damag
coinfect
superinfect
demonstr
within
chimpanze
woodchuck
inocul
human
hepat
recent
publish
report
demonstr
use
human
chimer
mous
studi
interact
two
virus
drug
test
ideal
anim
model
human
viral
diseas
close
recapitul
spectrum
clinic
symptom
pathogenesi
observ
cours
human
infect
whenev
feasibl
model
use
viru
strain
infect
human
also
prefer
viru
low
passag
clinic
isol
thu
anim
passag
adapt
avoid
model
speci
identifi
suscept
ideal
experiment
rout
infect
would
mirror
occur
natur
diseas
understand
interplay
contribut
immun
system
infect
immunocompet
anim
use
characterist
alway
satisfi
howev
often
viru
must
adapt
knockout
mice
must
use
andor
diseas
perfectli
mimick
anim
model
wellcharacter
anim
model
critic
licensur
satisfi
food
fda
anim
rule
rule
appli
situat
vaccin
therapeut
safe
ethic
test
human
thu
licensur
come
preclin
test
perform
anim
model
mani
field
virolog
move
toward
standard
model
use
across
institut
test
vaccin
therapeut
current
exampl
effort
within
filoviru
commun
anim
model
euthanasia
criteria
assay
viru
strain
process
standard
hope
effort
enabl
result
efficaci
test
medic
countermeasur
compar
across
institut
chapter
summar
best
model
avail
virus
describ
